<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">ArXiv</journal-id><journal-id journal-id-type="iso-abbrev">ArXiv</journal-id><journal-id journal-id-type="pmc-domain-id">3862</journal-id><journal-id journal-id-type="pmc-domain">arxiv</journal-id><journal-id journal-id-type="publisher-id">arxiv</journal-id><journal-title-group><journal-title>ArXiv</journal-title></journal-title-group><issn pub-type="epub">2331-8422</issn><publisher><publisher-name>arXiv</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11601800</article-id><article-id pub-id-type="pmcid-ver">PMC11601800.1</article-id><article-id pub-id-type="pmcaid">11601800</article-id><article-id pub-id-type="pmcaiid">11601800</article-id><article-id pub-id-type="pmid">39606727</article-id><article-id pub-id-type="arxiv">arXiv:2411.10421v1</article-id><article-id pub-id-type="publisher-id">2411.10421</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version article-version-type="number">1</article-version><article-version article-version-type="status">preprint</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Deciphering <italic toggle="yes">SCN2A</italic>: A comprehensive review of rodent models of <italic toggle="yes">Scn2a</italic> dysfunction</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Scott</surname><given-names initials="KEJ">Katelin E.J</given-names></name><xref rid="A1" ref-type="aff">1</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Hermosillo Arrieta</surname><given-names initials="MF">Maria F.</given-names></name><xref rid="A2" ref-type="aff">2</xref><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">&#8224;</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Williams</surname><given-names initials="AJ">Aislinn J.</given-names></name><xref rid="A3" ref-type="aff">3</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">&#8224;</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Interdisciplinary Neuroscience Graduate Program</aff><aff id="A2"><label>2</label>iDREAM</aff><aff id="A3"><label>3</label>Iowa Neuroscience Institute</aff><aff id="A4"><label>4</label>Department of Psychiatry</aff><author-notes><fn fn-type="con" id="FN1"><label>&#8224;</label><p id="P1">University of Iowa, Iowa City, Iowa</p></fn><corresp id="CR1"><label>*</label>Correspondence: Dr. Aislinn Williams, <email>aislinn-williams@uiowa.edu</email></corresp></author-notes><pub-date pub-type="epub"><day>15</day><month>11</month><year>2024</year></pub-date><issue-id pub-id-type="pmc-issue-id">475927</issue-id><elocation-id>arXiv:2411.10421v1</elocation-id><pub-history><event event-type="pmc-release"><date><day>15</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>28</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-08 14:25:14.080"><day>08</day><month>09</month><year>2025</year></date></event></pub-history><permissions><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This work is licensed under a <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International License</ext-link>, which allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihpp-2411.10421v1.pdf"/><self-uri content-type="pdf">nihpp-2411.10421v1.pdf</self-uri><related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="published-article" xml:lang="en" journal-id="Epilepsia" journal-id-type="nlm-ta" ext-link-type="pubmed" xlink:href="40884529"><article-title>Deciphering SCN2A: A comprehensive review of rodent models of Scn2a dysfunction.</article-title><date><day>30</day><month>8</month><year>2025</year></date><source>Epilepsia</source><pub-id pub-id-type="doi">10.1111/epi.18615</pub-id><pub-id pub-id-type="pmid">40884529</pub-id></related-article><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="S1"><title>Background</title><p id="P2"><italic toggle="yes">SCN2A</italic> related disorders are highly heterogeneous and manifest in a variety of diagnoses including self-limited familial and non-familial infantile epilepsy (SeLFNIE) (previously benign familial infantile seizures or BFNIS) (<xref rid="R39" ref-type="bibr">Lauxmann et al., 2018</xref>), epileptic encephalopathies (EE) (<xref rid="R1" ref-type="bibr">Adney et al., 2020</xref>; <xref rid="R6" ref-type="bibr">Berecki et al., 2018</xref>; <xref rid="R29" ref-type="bibr">Kamiya et al., 2004</xref>; <xref rid="R41" ref-type="bibr">J. Li et al., 2016</xref>; <xref rid="R44" ref-type="bibr">Liao et al., 2010</xref>; <xref rid="R58" ref-type="bibr">Ogiwara et al., 2009</xref>; <xref rid="R69" ref-type="bibr">Shi et al., 2012</xref>), infantile spasms (<xref rid="R76" ref-type="bibr">Sundaram et al., 2013</xref>), ataxia (<xref rid="R54" ref-type="bibr">Murray et al., 2023</xref>), autism spectrum disorder (ASD) (<xref rid="R5" ref-type="bibr">Ben-Shalom et al., 2017</xref>; <xref rid="R66" ref-type="bibr">Sanders et al., 2018</xref>; <xref rid="R86" ref-type="bibr">Weiss et al., 2003</xref>), intellectual disability (ID) (<xref rid="R4" ref-type="bibr">Begemann et al., 2019</xref>; <xref rid="R41" ref-type="bibr">J. Li et al., 2016</xref>), and schizophrenia (<xref rid="R12" ref-type="bibr">Carroll et al., 2016</xref>; <xref rid="R21" ref-type="bibr">Fromer et al., 2014</xref>; <xref rid="R41" ref-type="bibr">J. Li et al., 2016</xref>; <xref rid="R75" ref-type="bibr">Suddaby et al., 2019</xref>). These disorders have been associated with functional alterations. <italic toggle="yes">SCN2A</italic> encodes the alpha subunit of the voltage-gated sodium channel Na<sub>v</sub>1.2, which is involved in action potential initiation and backpropagation in glutamatergic neurons (<xref rid="R27" ref-type="bibr">Hu et al., 2009</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>).</p><p id="P3">Researchers have attempted to elucidate the complexity of <italic toggle="yes">SCN2A</italic>-related disorders through non-human mammalian models. This review aims to evaluate and compare the published rodent models to consolidate findings, identify limitations, and highlight future research directions (<xref rid="SD1" ref-type="supplementary-material">Supplemental Table 1</xref>). Thus far, over 30 <italic toggle="yes">Scn2a</italic> mouse models have been engineered and published, and there are at least 2 other rodent models, beyond mice, available for <italic toggle="yes">SCN2A</italic> research. For a review of non-mammalian models and mechanisms of <italic toggle="yes">SCN2A</italic>-Related Disorders, please see Hedrich et al., 2020 and <xref rid="R37" ref-type="bibr">Kruth et al., 2020</xref>.</p><sec id="S2"><title>Mouse Models of <italic toggle="yes">Scn2a</italic> Insufficiency</title><sec id="S3"><title>First <italic toggle="yes">Scn2a</italic> Constitutive Haploinsufficient Mouse Model</title><p id="P4">The first published <italic toggle="yes">Scn2a</italic> mouse model was created by disrupting the first 89 amino acids in exon 1 of the <italic toggle="yes">Scn2a</italic> gene via homologous recombination (<xref rid="R63" ref-type="bibr">Planells-Cases et al., 2000</xref>). This mouse model revealed that homozygous knockout of <italic toggle="yes">Scn2a</italic> is perinatally lethal in mice. The <italic toggle="yes">Scn2a</italic> haploinsufficient (<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>) mouse model was viable and able to reproduce. Since 2000, the Planells-Cases model has been widely used and robustly characterized (<xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>; <xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>; <xref rid="R47" ref-type="bibr">Marcantonio et al., 2023</xref>; <xref rid="R49" ref-type="bibr">Middleton et al., 2018</xref>; <xref rid="R51" ref-type="bibr">Misra et al., 2008</xref>; <xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R56" ref-type="bibr">Nelson et al., 2024</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>, <xref rid="R72" ref-type="bibr">2021</xref>; <xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>; <xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>; <xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). It is likely the most extensively characterized model of <italic toggle="yes">SCN2A</italic>-related disorders.</p><p id="P5">Although robustly characterized, there are some conflicting behavioral results from the various studies utilizing the model. For instance, <xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref> found that <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice were hypersocial compared to their wildtype littermate controls and <xref rid="R47" ref-type="bibr">Marcantonio et al., 2023</xref> identified a similar phenotype in juvenile female <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>mice. However, <xref rid="R40" ref-type="bibr">L&#233;na and Mantegazza, 2019</xref>, found mild social behavior deficits in juvenile male <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice that attenuated with age. Some studies also found no differences between the sociability of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice and their littermate controls (<xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>). A summary of general behavioral findings from the (<xref rid="R63" ref-type="bibr">Planells-Cases et al., 2000</xref>) <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mouse model is provided in <xref rid="F1" ref-type="fig">Figure 1</xref> and <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>.</p><p id="P6">When first characterized, it was thought that <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice did not experience seizures (<xref rid="R51" ref-type="bibr">Misra et al., 2008</xref>; <xref rid="R63" ref-type="bibr">Planells-Cases et al., 2000</xref>), but recently, electrographic spontaneous absence-like seizures have been reported in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). The authors suggested that the &#8221;outwardly healthy appearance&#8221; of the mice could be why past seizure activity had been undetected (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). Now there are also reported cases of this model having convulsive seizures: <xref rid="R67" ref-type="bibr">Schamiloglu et al.,2023</xref> identified 16% of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice actively seizing at the end of a dynamic foraging behavior task. The mice used in the task had restricted water consumption before testing, which could have induced the seizures (<xref rid="R67" ref-type="bibr">Schamiloglu et al., 2023</xref>). This raises the possibility that the severity and type of seizure endured by <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice can be modulated by experience.</p><p id="P7">Beyond seizures, the Planells-Cases <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice have been found to have slower and more broad action potential generation, at least in the first postnatal week (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>; <xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). Additionally, immature glutamatergic cortical neurons from <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice display decreased neuronal excitability, but mature neurons from these animals are hyperexcitable (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>, <xref rid="R72" ref-type="bibr">2021</xref>). These findings indicate that impairments in action potential depolarization and cell excitability may depend on developmental stage. Additionally, partial loss of Na<sub>v</sub>1.2 impaired cortical-striatal firing and may contribute to the identified seizures through maladaptive changes in the cortical-striatal circuit (<xref rid="R27" ref-type="bibr">Hu et al., 2009</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). Haploinsufficiency of Na<sub>v</sub>1.2 also impaired dendritic excitability and backpropagation, which can further alter neuron repolarization and activity (<xref rid="R56" ref-type="bibr">Nelson et al., 2024</xref>). Overall, constitutive <italic toggle="yes">Scn2a</italic> haploinsufficiency appears to impair excitatory cortical neurons in a developmental stage-specific manner and increases seizure susceptibility, although the precise mechanism linking these changes remains unknown.</p></sec><sec id="S4"><title>Other Constitutive Haploinsufficient Mouse Models</title><p id="P8">Additional constitutive haploinsufficient <italic toggle="yes">Scn2a</italic> mouse models exist. While not as well characterized as the Planells-Cases model, they provide further insight into the behavioral and physiologic effects of various genetic disruptions inducing Na<sub>v</sub>1.2 haploinsufficiency.</p><p id="P9">In one such model, the adult Na<sub>v</sub>1.2 channel isoform was expressed in neonatal animals using homologous recombination (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). A targeting construct leading to the desired mutation was injected into blastocysts of C57BL/6 mice to obtain chimeric mice, which were then bred with wildtype C57BL/6 mice (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). The resulting offspring were then crossed with a cre-transgenic mouse strain B6.C-Tg(CMV-Cre)1Cgn/J to remove the neomycin cassette and thus generate a stable and constitutive line of heterozygous Na<sub>v</sub>1.2<sup>adult/+</sup> mutants, simply referred to as Na<sub>v</sub>1.2<sup>adult</sup> mice (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). The neonatal and adult isoforms of <italic toggle="yes">Scn2a</italic> are only one nucleotide different from one another in exon 5; the neonatal isoform (5N) expresses an asparagine at residue 209, while the adult isoform (5A) expresses aspartic acid at the same position (<xref rid="R23" ref-type="bibr">Gazina et al., 2010</xref>, <xref rid="R22" ref-type="bibr">2015</xref>; <xref rid="R37" ref-type="bibr">Kruth et al., 2020</xref>). 5N is less excitable than 5A, and when 5A was expressed in neonatal mice, they demonstrated signs of hyperactivity and seizure activity (<xref rid="F2" ref-type="fig">Figure 2</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>) (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). Data from the human channel also supports the idea of different electrophysical profiles between the two Na<sub>v</sub>1.2 isoforms. Some gain of function human variants cause the Na<sub>v</sub>1.2 5N isoform to mimic the electrophysical properties of 5A, leading to seizures (<xref rid="R53" ref-type="bibr">Muller, 2020</xref>; <xref rid="R80" ref-type="bibr">Thompson et al., 2020</xref>). The change in electrophysical properties of Na<sub>v</sub>1.2 during the neonatal period may explain why these individuals had seizure profiles in infancy that attenuated with age (<xref rid="R53" ref-type="bibr">Muller, 2020</xref>; <xref rid="R80" ref-type="bibr">Thompson et al., 2020</xref>). Since the neonatal isoform of <italic toggle="yes">Scn2a</italic> has different electrophysical properties than the adult isoform and can lead to different phenotypic effects when altered, Na<sub>v</sub>1.2 5N and 5A need to be further investigated to elucidate the functional roles of both in <italic toggle="yes">SCN2A</italic>-related disorders.</p><p id="P10">Another constitutive model deleted exons 4&#8211;6 to induce Na<sub>v</sub>1.2 haploinsufficiency (<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup>) (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>). Although a large part of the coding sequence for <italic toggle="yes">Scn2a</italic> was removed, including exon 5 that encodes for the 5N and 5A isoforms, about 60% expression of <italic toggle="yes">Scn2a</italic> was maintained in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup> mice (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>). <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup> mice did not display spontaneous seizure activity but did display decreases in neuronal activity and excitatory synaptic transmission (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>). Additionally, a close electrophysical investigation of hippocampi from these mice revealed that the Schaffer collateral-CA1 pathway of these animals was typical; however, long-term potentiation was suppressed without affecting long-term depression through mechanisms independent of NMDAR-mediated synaptic transmission (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>). Furthermore, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup> had impairments in reversal learning but displayed no measurable changes in grooming and anxiety-like behaviors (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>)(<xref rid="F2" ref-type="fig">Figure 2</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>). It is important to mention that although no changes in anxiety-like behavior were detected, juvenile <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">fl/+</italic></sup> mice displayed less overall locomotion in the open field test than their wildtype counterparts. This finding could further highlight a potential difference in the role of Na<sub>v</sub>1.2 in juvenile vs adult animals (<xref rid="R70" ref-type="bibr">Shin et al., 2019</xref>). Furthermore, RNA scope data from the <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">fl/+</italic></sup> mice indicate that <italic toggle="yes">Scn2a</italic> mRNA is expressed in both GABAergic and glutamatergic neurons of the neocortex and hippocampus in adult animals, suggesting that <italic toggle="yes">Scn2a</italic> could also function and exist in inhibitory cells.</p><p id="P11">A similar construct, the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/KI</italic></sup> model, was generated by deleting exons 3&#8211;5 of one <italic toggle="yes">Scn2a</italic> allele and inserting an in-frame eGFP sequence to visualize cells that expressed <italic toggle="yes">Scn2a</italic> (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). Seizures were induced in these animals with pentylenetetrazole, but no difference was identified in susceptibility to seizures between <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/KI</italic></sup> and wildtype C57BL/6J mice (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). These additional constitutive <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> models indicate that although all express between 50% to 60% of native <italic toggle="yes">Scn2a</italic> protein, the effect of each manipulation does not have an identical impact on phenotypic presentation.</p><p id="P12">There is also at least one model that paired the Planells-Cases <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mouse with a <italic toggle="yes">Kcna1</italic><sup><italic toggle="yes">+/&#8211;</italic></sup> mouse to generate mice heterozygous for both genes or heterozygous for <italic toggle="yes">Scn2a</italic> but null for <italic toggle="yes">Kcna1</italic> (<xref rid="R50" ref-type="bibr">Mishra et al., 2017</xref>). <italic toggle="yes">Kcna1</italic> encodes for K<sub>V</sub>1.1, a voltage-gated potassium channel, and is a monogenetic risk gene for epilepsy. The mixed model enabled a close investigation of how <italic toggle="yes">Scn2a</italic> and potassium channels interact, which is discussed in more detail later in this manuscript. Both <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup>+/&#8722;</sup> mice and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup>&#8722;/&#8722;</sup> animals had attenuated repetitive behaviors compared <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice and were more similar to wildtype C57BL/6J mice (<xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>). It has also been noted that the seizure phenotype apparent in <italic toggle="yes">Kcna1</italic><sup>&#8722;/&#8722;</sup> was attenuated in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup>&#8722;/&#8722;</sup> mice (<xref rid="R50" ref-type="bibr">Mishra et al., 2017</xref>). The improvements in behavior and seizure phenotype of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup>+/&#8722;</sup> and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup>&#8722;/&#8722;</sup> suggest that Na<sub>v</sub>1.2 and Kv1.1 may be therapeutic targets for one another and are likely playing a compensatory role for each other when one is impaired. When both channels are partially lost, there appears to be a synergistic positive effect on overall health outcomes, likely because the channels cannot overcompensate for one another and cause maladaptive changes.</p><p id="P13">Lastly, another haploinsufficient <italic toggle="yes">Scn2a</italic> mouse model was generated by creating a point mutation at amino acid 38, which switched Lys for Gln (<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">K38Q</italic></sup>) (<xref rid="R36" ref-type="bibr">Kotler et al., 2023</xref>). This point mutation removed the only SUMO-conjugation site in Na<sub>v</sub>1.2 channels (<xref rid="R36" ref-type="bibr">Kotler et al., 2023</xref>). This model helped reveal that SUMOylation of Na<sub>v</sub>1.2 channels prolongs the decay time constant of EPSPs greater than 10 mV in amplitude, but this effect is lost in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">K38Q</italic></sup> mice. Furthermore, SUMOylation was found to impact the speed of forward and backpropagating action potentials of cortical pyramidal cells from <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">K38Q</italic></sup> mice (<xref rid="R36" ref-type="bibr">Kotler et al., 2023</xref>). These findings indicate that changes in SUMOylation and possibly other post-transcriptional modifications influence the observed changes in action potential back-propagation observed in <italic toggle="yes">Scn2a</italic> mutant mice.</p></sec><sec id="S5"><title>Hypomorphic <italic toggle="yes">Scn2a</italic> mouse models</title><p id="P14">Most <italic toggle="yes">Scn2a</italic> constitutive loss of function (LOF) mouse models result in <italic toggle="yes">Scn2a</italic> haploinsufficiency and retain around 50% of Na<sub>v</sub>1.2 channel expression. However, there are at least two constitutive <italic toggle="yes">Scn2a</italic> models that result in less than 50% of Na<sub>v</sub>1.2 channel expression; a severe hypomorph and a gene trap model(<xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). These models both retain around 25% or less of Na<sub>v</sub>1.2 channel expression. As global homozygous loss of Scn2a results in perinatal death, these models have been instrumental in exploring the consequences of severe loss of <italic toggle="yes">Scn2a</italic> without complete deletion.</p><p id="P15">The severe <italic toggle="yes">Scn2a</italic> hypomorphic mouse was engineered using Crispr-Cas9 to induce a 27-base pair frameshift in the C-terminal region of the <italic toggle="yes">Scn2a</italic> protein creating <italic toggle="yes">Scn2a</italic><sup>&#916;1898/+</sup>(<xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>), which resulted in &#8804;25% or less of native Na<sub>v</sub>1.2 (<xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). <italic toggle="yes">Scn2a</italic><sup>&#916;1898/+</sup> mice displayed hyperactivity and reduced anxiety-like behaviors, which is similar to other <italic toggle="yes">SCN2A</italic> LOF models (<xref rid="F3" ref-type="fig">Figure 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>) (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>; <xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>; <xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>; <xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). Additionally, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">&#916;1898/+</italic></sup> mice displayed increased social behaviors, which aligns with observations from individuals with <italic toggle="yes">SCN2A</italic>-related disorders (<xref rid="F3" ref-type="fig">Figure 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>)(<xref rid="R66" ref-type="bibr">Sanders et al., 2018</xref>). Cultured excitatory cortical pyramidal neurons from <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">&#916;1898/+</italic></sup> mice displayed both reduced voltage-gated Na+ channel currents and reduced neuronal excitability, but inhibitory neurons were unchanged (<xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). Brain slices from these animals further revealed reduced excitatory synaptic input onto cortical pyramidal neurons (<xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>).</p><p id="P16">A <italic toggle="yes">SCN2A</italic> model created using a Tm1a trapping cassette (<italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup>) reduced Na<sub>v</sub>1.2 expression to around 25% that of wildtype similar to the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">&#916;1898/+</italic></sup> mouse (<xref rid="R16" ref-type="bibr">Eaton et al., 2021</xref>; <xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). The <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup> displayed significant alterations in innate behaviors like nest building and grooming (<xref rid="F3" ref-type="fig">Figure 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>) (<xref rid="R16" ref-type="bibr">Eaton et al., 2021</xref>). These mice also had increased anxiety-like behaviors, which contrasts the behavioral findings seen in other models of <italic toggle="yes">Scn2a</italic> loss (<xref rid="F3" ref-type="fig">Figure 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>) (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>; <xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>; <xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>; <xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). Adult <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup> mice were found to have increased neuronal excitability, which co-occurred with a higher voltage threshold in medium spiny neurons, which parallels the paradoxical hyperexcitability of cortical pyramidal neurons lacking Na<sub>v</sub>1.2 (MSNs) (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>; <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). There was reduced expression and current outputs of some potassium channels in these mice, likely to compensate for the increased excitability induced by Na<sub>v</sub>1.2 depletion ( <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). These results indicate that changes in neuronal excitability due to Na<sub>v</sub>1.2 reduction are dependent on both levels of <italic toggle="yes">SCN2A</italic> expression and cell type. Regardless, the hyperexcitability of some neuron types in response to Na<sub>v</sub>1.2 loss/reduction is likely contributing to the seizure disorders experienced by individuals with LOF <italic toggle="yes">SCN2A</italic> mutations (<xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Microglia in the <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup> mice have morphology changes distinct from wildtype C57BL/6N mice and may contribute to some of the noted phenotypes in these animals (<xref rid="R89" ref-type="bibr">Wu et al., 2024</xref>). The <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup> mice further had alterations in the core clock genes and the suprachiasmatic nucleus, leading to altered sleep patterns (<xref rid="F3" ref-type="fig">Figure 3</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>) (<xref rid="R45" ref-type="bibr">Ma et al., 2022</xref>). This is the first model of <italic toggle="yes">SCN2A</italic> loss to evaluate sleep disturbances, although they are commonly reported in individuals with <italic toggle="yes">SCN2A</italic>-related disorders (<xref rid="R66" ref-type="bibr">Sanders et al., 2018</xref>). Alterations in sleep architecture and regulation should be further investigated in other <italic toggle="yes">SCN2A</italic> models to gain further insight into Na<sub>v</sub>1.2&#8217;s role in sleep. Improving the understanding of Na<sub>v</sub>1.2&#8217;s role in sleep can enhance the treatment of <italic toggle="yes">SCN2A</italic>-related sleep disorders by identifying affected sleep cycles and mechanisms, leading to more precise treatment targets.</p></sec><sec id="S6"><title>Conditional and tissue specific deletion of <italic toggle="yes">Scn2a</italic> in mice</title><p id="P17">There are multiple <italic toggle="yes">Scn2a</italic> models that either reduce <italic toggle="yes">Scn2a</italic> levels at a specific age or induce tissue-specific changes in <italic toggle="yes">Scn2a</italic> expression. Many of these models utilize Cre-driver lines to induce conditional deletion of <italic toggle="yes">Scn2a</italic> in specific tissue and cell types (<xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref>; <xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>, <xref rid="R72" ref-type="bibr">2021</xref>; <xref rid="R77" ref-type="bibr">Suzuki et al., 2023</xref>; <xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>; <xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>; <xref rid="R85" ref-type="bibr">H.-G. Wang et al., 2021</xref>). Other models utilize unique approaches like short-hairpin RNAs and antisense oligonucleotides (<xref rid="R42" ref-type="bibr">M. Li et al., 2023</xref>; <xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>).</p><p id="P18">Expressing shRNAs on postnatal day 21 enabled the deletion of Na<sub>v</sub>1.2 in olfactory bulb granule cells (ObGC), which enabled the investigation of Na<sub>v</sub>1.2&#8217;s involvement in odor discrimination (<xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>). Na<sub>v</sub>1.2 channels are expressed along the cell surface and dendritic spines obGCs, and removal of <italic toggle="yes">Scn2a</italic> from obGCs was found to impair rapid and accurate odor discrimination (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>) (<xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>). Impaired odor discrimination was likely due to inhibition of synaptically connected mitral cells, diminished GABA release, and reduced granule cell spiking, which were all consequences of Na<sub>v</sub>1.2 deletion in obGC (<xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>). Currently, this is the only model to identify impaired odor discrimination in <italic toggle="yes">Scn2a</italic> mutant mice; investigations utilizing the Planells-Cases <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mouse have not revealed a difference in odor discrimination between mutant mice and their wildtype counterparts (<xref rid="R16" ref-type="bibr">Eaton et al., 2021</xref>; <xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>). These conflicting findings suggest that a threshold of Na<sub>v</sub>1.2 is necessary for rapid and accurate odor discrimination.</p><p id="P19">Another unique method to reduce Scn2a expression relied on antisense oligonucleotides (ASO). An ASO was injected into the ventricles of 2 to 3-month-old Rbp4-Cre mice to both truncate <italic toggle="yes">Scn2a</italic> and create <italic toggle="yes">Scn2a</italic> insufficiency and selectively label L5 pyramidal neurons (<xref rid="R42" ref-type="bibr">M. Li et al., 2023</xref>). The <italic toggle="yes">Scn2a</italic> ASO mice displayed reduced sociability and increased hyperactivity and anxiety-like behaviors (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>). These mice also lost innate nest building, similar to data from <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">gtKO/gtKO</italic></sup> mice (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>) (<xref rid="R42" ref-type="bibr">M. Li et al., 2023</xref>). Ca<sup>2+</sup> transient currents were also reduced in <italic toggle="yes">Scn2a</italic> ASO mice, which decreased spontaneous cortical somatosensory neuronal firing and pairwise co-activation (<xref rid="R42" ref-type="bibr">M. Li et al., 2023</xref>). This study wanted to utilize the <italic toggle="yes">Scn2a</italic> ASO mouse model as a proxy for identifying the consequences of premature truncating variants (PTV). However, <italic toggle="yes">Scn2a</italic> haploinsufficiency is not generated until mice are between 2 and 3 months of age and neural networks have been fully established. Therefore, this model may not fully capture how prematurely truncating <italic toggle="yes">SCN2A</italic> can change neural circuits and signaling as the animal developed typically until induction and critical periods of Na<sub>v</sub>1.2 involvement could have been missed.</p><p id="P20">Cre-driver lines have been commonly utilized to generate developmental stage, cell, and tissue-specific deletion or reduction of <italic toggle="yes">Scn2a</italic>. For instance, two Cre driver lines were utilized to delete <italic toggle="yes">Scn2a</italic> in either forebrain excitatory neurons <italic toggle="yes">(Emx1</italic>-Cre<italic toggle="yes">)</italic> or global deletion in inhibitory neurons (<italic toggle="yes">Vgat</italic>-Cre) in an <italic toggle="yes">Scn2a</italic> floxed animal (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). Based on western blot data from P0.5 animals, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/fl/</italic></sup><italic toggle="yes">Emx1-Cre</italic> had a 30% reduction of Na<sub>v</sub>1.2, while <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/fl/</italic></sup><italic toggle="yes">Vgat-Cre</italic> resulted in around a 60% reduction of Na<sub>v</sub>1.2 expression, further confirming that at least early postnatal mice express Na<sub>v</sub>1.2 in both excitatory and inhibitory neurons (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). Both <italic toggle="yes">Scn2a</italic><sup>fl/fl/</sup><italic toggle="yes">Emx1</italic>-Cre and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/fl/</italic></sup><italic toggle="yes">Vgat-Cre</italic> mice died within a few days of birth, likely due to homozygous loss of Na<sub>v</sub>1.2 (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). Western blot of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Emx1-Cre</italic> and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Vgat-Cre</italic> adult animals, however, revealed that <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Emx1-Cre</italic> had around 50% reduced Na<sub>v</sub>1.2 expression in neocortex and hippocampus, but no significant reduction of Na<sub>v</sub>1.2 was noted in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Vgat-Cre</italic> mice, suggesting that in adult animals Na<sub>v</sub>1.2 is mainly expressed in excitatory neurons (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). Furthermore, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Emx1-Cre</italic> and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Vgat-Cre</italic> mice were viable, fertile, and outwardly healthy, although about a third of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+/</italic></sup><italic toggle="yes">Vgat-Cre</italic> mice died unexpectedly around P18 - P25 of unknown causes (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). The unexplained and sporadic early death in <italic toggle="yes">Scn2a</italic><sup>fl/+/</sup><italic toggle="yes">Vgat</italic>-Cre mice could point to Na<sub>v</sub>1.2 having an important role in inhibitory cells early in development that is currently not understood. <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice have also been bred with a Vgat-venus line to fluorescently label inhibitory neurons to discern them from excitatory (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). The Vgat-venus/<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice helped determine that inhibitory cells do not experience the same alterations in excitability demonstrated in glutamatergic excitatory neurons, which indicates that loss of Na<sub>v</sub>1.2 impacts inhibitory and excitatory cells in distinct ways.</p><p id="P21">Behaviorally, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup><italic toggle="yes">/Emx1-Cre</italic> had significantly more rearing events in the open field assay than wildtype C57BL/6J littermates (<xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>). <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup><italic toggle="yes">/Emx1-Cre</italic> mice further displayed signs of possible hyperactivity and decreased anxiety-like phenotypes in the open field test. <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup><italic toggle="yes">/Vgat-Cre</italic> mice did not display these phenotypes in the open field test, but in the elevated plus maze, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/+</italic></sup><italic toggle="yes">/Vgat-Cre</italic> mice demonstrated reduced anxiety-like phenotypes (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>) (<xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>). These results suggest that Na<sub>v</sub>1.2 loss in dorsal-telencephalic excitatory neurons contributes to hyperactivity and repetitive behaviors, while anxiety-like phenotypes change in distinct ways when Na<sub>v</sub>1.2 is lost in dorsal-telencephalic excitatory neurons or inhibitory neurons. Na<sub>v</sub>1.2 expression in inhibitory neurons may be related to risk behavior, and loss of Na<sub>v</sub>1.2 in these cells is what is driving the mice to explore more in the elevated plus maze. In contrast, Na<sub>v</sub>1.2 in dorsal-telencephalic excitatory neurons may be more related to general exploration and locomotion, which is why there are different performances on the open field and elevated plus maze between the two conditional models.</p><p id="P22">ECoG data from <italic toggle="yes">Scn2a</italic><sup>fl/+</sup>/<italic toggle="yes">Emx1-Cre</italic> mice indicates that these animals have absence-like seizure activity and these animals further displayed spike-wave discharges (SWDs) during moments of behavioral quiescence which is typical of seizure activity (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>) (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>). However, <italic toggle="yes">Scn2a</italic><sup>fl/+</sup>/<italic toggle="yes">Vgat-Cre</italic> mice did not display seizure activity or behavioral quiescence (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). These data indicate that partial loss of Na<sub>v</sub>1.2 in inhibitory neurons is unlikely to be driving seizures in these animals, but partial loss of Na<sub>v</sub>1.2 in forebrain excitatory neurons is sufficient to cause seizures. Two other Cre-driver <italic toggle="yes">Scn2a</italic> models were engineered using the same <italic toggle="yes">Scn2a</italic> floxed mouse to elucidate if the SWDs had specific cortical striatal involvement (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). The new lines, <italic toggle="yes">Scn2a</italic><sup>fl/fl</sup>/<italic toggle="yes">Trpc-Cre</italic> mice and <italic toggle="yes">Scn2a</italic><sup>fl/fl</sup>/<italic toggle="yes">Ntsr-Cre</italic> mice, deleted <italic toggle="yes">Scn2a</italic> from cortical layer 5 (L5) and cortical layer 6 pyramidal neurons (L6) respectively (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). <italic toggle="yes">Scn2a</italic><sup>fl/fl</sup>/<italic toggle="yes">Trpc-Cre</italic> mice, but not <italic toggle="yes">Scn2a</italic><sup>fl/fl</sup>/<italic toggle="yes">Ntsr-Cre</italic> mice, displayed SWDs that matched the previously identified seizure phenotype, which indicates that L5 neurons and not L6 are likely involved in the identified absence seizure phenotype (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). Further research will be needed to illuminate how each subclass of L5 neurons, intratelencephalic or extratelencephalic, is involved.</p><p id="P23">Bilateral injections of adeno-associated virus (AAV) expressing Cre recombinase were injected into <italic toggle="yes">Scn2a</italic><sup>fl/fl</sup> mice to selectively delete <italic toggle="yes">Scn2a</italic> from mPFC or VTA to elucidate the role of Na<sub>v</sub>1.2 in schizophrenia (<xref rid="R77" ref-type="bibr">Suzuki et al., 2023</xref>). When <italic toggle="yes">Scn2a</italic> was depleted in the mPFC, prepulse inhibition (PPI) was reduced; however, an increase in PPI response was found when <italic toggle="yes">Scn2a</italic> was depleted in the VTA (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>) (<xref rid="R77" ref-type="bibr">Suzuki et al., 2023</xref>). Additionally, deletion of <italic toggle="yes">Scn2a</italic> in the mPFC was found to increase social interaction and anxiety-like behaviors but decrease locomotion when compared to control-treated animals; this effect was not seen when <italic toggle="yes">Scn2a</italic> was deleted in the VTA (<xref rid="F4" ref-type="fig">Figure 4</xref>, <xref rid="SD1" ref-type="supplementary-material">Supplemental Table 2</xref>) (<xref rid="R77" ref-type="bibr">Suzuki et al., 2023</xref>). AAV-EF1&#945;-Cre-mCherry has also been utilized to delete <italic toggle="yes">Scn2a</italic> in mPFC and label excitatory cells in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/fl</italic></sup> mice to explore Na<sub>v</sub>1.2 function without a specific focus on schizophrenia (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). When Na<sub>v</sub>1.2 is deleted from mature cortical pyramidal cells in the mPFC, the cells become paradoxically hyperexcitable (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). However, these cortical neurons also had a hypoexcitable response for dendritic backpropagation, which impaired axonal repolarization (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). Both the paradoxical hyperexcitability of the axon and the hypoexcitable dendritic backpropagation can be explained by Nav1.2&#8217;s unique role in regulating somatodendritic excitability through potassium channel priming (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>, <xref rid="R72" ref-type="bibr">2021</xref>). Reduced dendritic backpropagation results in fewer potassium channels opening to repolarize the neuron and establish a refractory period, thus allowing for more action potentials while impairing repolarization. This phenomenon noted in Na<sub>v</sub>1.2 deficient cells is likely one of the mechanisms in how LOF of Na<sub>v</sub>1.2 can lead to seizure disorders but does not necessarily explain how the loss of Na<sub>v</sub>1.2 contributes to other neuropsychiatric or developmental disorders. These studies highlight that although <italic toggle="yes">Scn2a</italic> likely has cell type, developmental stage, and brain region specific roles, the mechanism of how Na<sub>v</sub>1.2 contributes to such a heterogeneous group of neuropsychiatric disorders and symptoms requires further investigation.</p><p id="P24">Another <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/fl</italic></sup> mouse under the CaMKII&#945;-Cre driver removed exon 2 of the <italic toggle="yes">Scn2a</italic> gene (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>) around P10. The <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/fl/</italic></sup><italic toggle="yes">CaMKII-Cre</italic> mice developed with standard action potential threshold and spike output (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>). At P10, the animals start expressing cre in neocortical pyramidal cells and can then be manipulated for <italic toggle="yes">Scn2a</italic> knockdown (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>). If knockdown was induced around P10 by P50 peak dV/dt overlapped with constitutive <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> cells (<xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>). Ex-vivo culture of pyramidal cells from the model identified impaired dendritic excitability and action potential backpropagation even when haploinsufficiency was induced around P50 (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). Additionally, conditional deletion of <italic toggle="yes">Scn2a</italic> in either parvalbumin or somatostatin-positive interneurons did not appear to impair excitability in these neurons, which is consistent with previous findings (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>).</p><p id="P25">Utilizing Gabra6-Cre, Na<sub>v</sub>1.2 has also been knocked down or deleted from cerebellar granule neurons (<xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). Unlike the cerebrum, where <italic toggle="yes">Scn2a</italic> gets downregulated in adulthood, cerebellar granule neurons express <italic toggle="yes">Scn2a</italic> at high levels throughout life (<xref rid="R23" ref-type="bibr">Gazina et al., 2010</xref>). When <italic toggle="yes">Scn2a</italic> was deleted in these cells using Gabra6-Cre, mice displayed a hypersensitive vestibular ocular reflex (VOR) gain (<xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). Interestingly, this parallels the VOR changes in humans with pathogenic <italic toggle="yes">SCN2A</italic> mutations (<xref rid="R13" ref-type="bibr">Carson et al., 2017</xref>; <xref rid="R66" ref-type="bibr">Sanders et al., 2018</xref>; <xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). The change in VOR is likely due to alterations between cerebellar granule neurons and Purkinje cell synapses. Heterozygous loss of Nav1.2 is most likely reducing the high-frequency transmission between cerebellar granule neurons and Purkinje cells, which can disrupt synaptic plasticity by impairing long-term potentiation and thus altering VOR (<xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>).</p><p id="P26">Although Na<sub>v</sub>1.2 is generally studied in neurons, it also functions in other nervous system cells. <xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref> demonstrated that Na<sub>v</sub>1.2 is necessary for spiking activity and maturation of a subset of oligodendroglia in the brainstem and cerebellum (<xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref>). To discover this, a <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">fl/f</italic></sup><italic toggle="yes">/Actin-Cre</italic> line was used to globally delete <italic toggle="yes">Scn2a</italic> in mice around P4 to P6 with tamoxifen injection (<xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref>). Deletion of Na<sub>v</sub>1.2 removed the subpopulation of spiking oligodendroglia but did not impact global oligodendroglia differentiation and maturation (<xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref>). <xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref> also confirmed the presence of these <italic toggle="yes">Scn2a</italic> expressing oligodendroglia in the white matter of Olive baboons, a non-human primate (<xref rid="R25" ref-type="bibr">Gould &amp; Kim, 2021</xref>). These data demonstrate that Na<sub>v</sub>1.2 plays an integral role in neuronal signaling and can impact the development of non-neuronal cells, which could explain the heterogeneous nature of the phenotypes seen in humans.</p></sec><sec id="S7"><title>Patient-derived <italic toggle="yes">Scn2a</italic> LOF Models</title><p id="P27">Currently, only one <italic toggle="yes">SCN2A</italic> model primarily functions as a LOF mutation. This model emulates the human variant p.R102X, a premature stop codon at position 102 in the protein, which in humans has a dominant negative effect (<xref rid="R29" ref-type="bibr">Kamiya et al., 2004</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). <italic toggle="yes">Scn2a</italic>
<sup>R102X/+</sup> mice were identified as having absence-like seizures although appearing outwardly healthy, similar to the Planells-Cases <italic toggle="yes">Scn2a</italic>
<sup>+/&#8722;</sup> model. At least one <italic toggle="yes">Scn2a</italic>
<sup>R102X/+</sup> mouse was recorded using ECoG&#8211;EMG having a convulsive seizure (<xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>). It would be interesting to know if the dominant negative effect identified in humans translates to the mouse model. There is also a naturally occurring <italic toggle="yes">Scn2a</italic> variant in the C3H mouse strain, p.V752F, that has a dominant negative effect (<xref rid="R60" ref-type="bibr">Oliva et al., 2014</xref>).</p></sec></sec><sec id="S8"><title>Gain of Function <italic toggle="yes">Scn2a</italic> Mouse Models</title><sec id="S9"><title>Scn2a<sup>Q54</sup></title><p id="P28">Shortly after the first <italic toggle="yes">Scn2a</italic> knockout model was published, Kearney et al. published the first <italic toggle="yes">Scn2a</italic> gain of function (GOF) model: the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mouse. In this model, the neuron-specific enolase (NSE) promoter drives the expression of FLAG-tagged <italic toggle="yes">Scn2a</italic> GAL879&#8211;881QQQ, where the mutation is located in the evolutionarily conserved S4-S5 linker region of domain two (<xref rid="R31" ref-type="bibr">Kearney et al., 2001</xref>). These mice displayed spontaneous seizures that originated in the hippocampus and increased in number and duration with age, eventually leading to premature death around 4 to 9 months (<xref rid="R31" ref-type="bibr">Kearney et al., 2001</xref>; <xref rid="R33" ref-type="bibr">Kile et al., 2008</xref>). High-frequency stimulation of hippocampal neurons in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice leads to increased neuronal oscillations after discharge and spontaneous activity consistent with hyperexcitability and seizure activity (<xref rid="R33" ref-type="bibr">Kile et al., 2008</xref>). Examination of hippocampi from adult <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice determined that the frequent and prolonged seizures caused significant neuronal loss and gliosis in the CA1, CA2, and CA3 regions of the hippocampus (<xref rid="R31" ref-type="bibr">Kearney et al., 2001</xref>; <xref rid="R33" ref-type="bibr">Kile et al., 2008</xref>). Furthermore, grooming, although preserved in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice, was rigid in structure and had atypical characteristics like prolonged bouts, abnormal postures, and repetitive motions (<xref rid="R33" ref-type="bibr">Kile et al., 2008</xref>). The rigid and irregular pattern of grooming in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice could be indicative of autism-like symptomatology and may further suggest changes in neural pathways that are influencing the microstructure of innate behaviors (<xref rid="R35" ref-type="bibr">H. Kim et al., 2016</xref>). A summary of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> findings is provided in <xref rid="F5" ref-type="fig">Figure 5</xref>.</p></sec><sec id="S10"><title>Background Strain Effects in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic> Mice</sup></title><p id="P29">The <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mouse was originally engineered on a mixed C57BL/6J x SJl/J (F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup>) background and had a severe seizure phenotype. However, when crossed to a congenic C57BL/6J background (B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup>), the seizure phenotype attenuated (<xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>, <xref rid="R9" ref-type="bibr">2009</xref>; <xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). Specifically, F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice display both greater evoked activity and increased firing frequency within the hippocampus compared to the B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice, although B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice still display increased hippocampal activity compared to wildtype mice (<xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). The level of persistent sodium current and depolarized inactivation of hippocampal pyramidal cells also correlated with the changes in firing frequency and evoked potentials between the two Q54 models (<xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>).</p><p id="P30">The change in seizure phenotype between background strains created an avenue to investigate genetic modifiers of <italic toggle="yes">Scn2a</italic>-related disorders. Identifying genetic modifiers of <italic toggle="yes">SCN2A</italic> could provide insight into why individuals with identical mutations do not present clinically with matching symptomology and severity. Genetic screening of both background strains identified loci on chromosomes 11 and 19, Modifier of epilepsy 1 (Moe1) and Modifier of epilepsy 2 (Moe2), respectively (<xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>). These loci accounted for around 80% of the observed differences in seizure susceptibility between the two strains (<xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>). Furthermore, the SJI background strain carries <italic toggle="yes">doubleridge (dblr)</italic>, a transgene-induced mouse mutation, in chromosome 19, which is also the location of the Moe2 locus (<xref rid="R46" ref-type="bibr">MacDonald et al., 2004</xref>). The <italic toggle="yes">dblr</italic> mutation reduces the expression of Dickkopf-1(<italic toggle="yes">Dkk1</italic>), a Wnt signaling inhibitor, and has been related to increased seizure events (<xref rid="R46" ref-type="bibr">MacDonald et al., 2004</xref>). However, reducing levels of <italic toggle="yes">Dkk1</italic> in B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice by crossing them with <italic toggle="yes">Dkk1</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice did not increase seizure susceptibility or incidence; thus, <italic toggle="yes">Dkk1</italic> is unlikely to be the genetic modifier of seizure severity between the two background strains of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice (<xref rid="R46" ref-type="bibr">MacDonald et al., 2004</xref>).</p><p id="P31">Fine mapping of chromosome 19 determined that the Moe2 locus within the <italic toggle="yes">dblr</italic> region is 21.8kb upstream of <italic toggle="yes">Dkk1</italic> (<xref rid="R9" ref-type="bibr">Bergren et al., 2009</xref>), thus supporting previous data indicating that <italic toggle="yes">Dkk1</italic> was not the modifier increasing seizure susceptibility. However, careful chromosome mapping identified twenty-four other potential genetic modifiers within the Moe2 locus (<xref rid="R9" ref-type="bibr">Bergren et al., 2009</xref>). Sequencing of the candidate genes uncovered non-synonymous coding sequence polymorphisms in the potassium channel gene <italic toggle="yes">Kcnv2</italic> (voltage-gated potassium channel subfamily V, member 2<italic toggle="yes">/</italic>K<sub>v</sub>8.2) and the transcription factor <italic toggle="yes">Smarca2</italic> (SWI/SNF related matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 2) (<xref rid="R9" ref-type="bibr">Bergren et al., 2009</xref>). Ultimately, <italic toggle="yes">Kcnv2</italic> was determined to be the strongest functional candidate of Moe2 locus involvement in the seizure phenotype differences observed between the F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> and B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice (<xref rid="R9" ref-type="bibr">Bergren et al., 2009</xref>). Knowing how genetic modifiers influence the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mouse phenotype helps elucidate how similar mutations can lead to disparate seizure and symptom profiles of individuals with <italic toggle="yes">SCN2A-</italic>related disorders.</p></sec><sec id="S11"><title><italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> Mice and Genetic Modulators of Seizure Severity</title><p id="P32">The pore-forming subunit of the T-type calcium channel Ca<sub>v</sub>3.1, <italic toggle="yes">Cacna1g,</italic> has been identified as a genetic modifier of seizure severity between the <italic toggle="yes">B6.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice and the <italic toggle="yes">F1.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup>mice (<xref rid="R11" ref-type="bibr">Calhoun et al., 2016</xref>). <italic toggle="yes">Cacna1g</italic> is located in the Moe1 locus. Elevation of Ca<sub>v</sub>3.1 correlated with increased spontaneous seizure activity, while a decrease in Ca<sub>v</sub>3.1 correlated with decreased seizure activity (<xref rid="R11" ref-type="bibr">Calhoun et al., 2016</xref>). Cacna1g could be a potential therapeutic target for the treatment of <italic toggle="yes">Scn2a</italic>-related epilepsies that do not respond to sodium or potassium channel blockers.</p><p id="P33">Hepatic leukemia factor (<italic toggle="yes">Hlf</italic>) is another genetic modifier of seizures in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice (<xref rid="R26" ref-type="bibr">Hawkins &amp; Kearney, 2016</xref>). Deletion of <italic toggle="yes">Hlf</italic> in <italic toggle="yes">B6.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice augments the seizure phenotype (<xref rid="R26" ref-type="bibr">Hawkins &amp; Kearney, 2016</xref>). <italic toggle="yes">Hlf</italic> is a regulator of the pyridoxine pathway, and it was postulated that deletion of <italic toggle="yes">Hlf</italic> exacerbated the severity of seizures through dysregulation of the pathway. When fed a diet deficient in pyridoxine, the number and severity of seizures of the <italic toggle="yes">B6.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice also increased (<xref rid="R26" ref-type="bibr">Hawkins &amp; Kearney, 2016</xref>). These findings reveal pyridoxine as a regulator of seizure severity in this mouse model (<xref rid="R26" ref-type="bibr">Hawkins &amp; Kearney, 2016</xref>).</p><p id="P34">Calmodulin protein kinase II (CaMKII), a modulator of persistent current and channel inactivation, alters and likely indicates seizure severity of <italic toggle="yes">SCN2A</italic>-related seizures (<xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). Higher levels of CaMKII were found in hippocampal lysates from the F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice (more severe phenotype) compared to <italic toggle="yes">B6.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup>mice (attenuated phenotype) (<xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). Both <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> lines, however, had elevated levels of CaMKII present compared to wildtype, which indicates that CaMKII levels rise in response to increased Na<sub>v</sub>1.2 activity. Lastly, inhibition of CaMKII in either F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> or <italic toggle="yes">B6.Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice reduced neuronal excitability and persistent currents, improving the seizure phenotype (<xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). The identification of multiple modifiers of <italic toggle="yes">Scn2a-</italic>related seizures in mice can uncover potential new targets for the treatment of <italic toggle="yes">SCN2A</italic>-related seizure disorders.</p></sec><sec id="S12"><title>Other <italic toggle="yes">Scn2a</italic> GOF models</title><p id="P35">Beyond <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup>, there are at least two other GOF <italic toggle="yes">Scn2a</italic> mouse models, both of which model human variants. The first is the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">A263V/+</italic></sup> mouse, which displays increased activity in hippocampal CA1 pyramidal neurons (<xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>). The <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">A263V/+</italic></sup> model was specifically developed to better understand sodium channel involvement in autoimmune encephalomyelitis (EAE) which leads to gradual disability through neuron loss (<xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>). The p.A263V mutant allele compounded the effect of EAE by increasing Na<sub>v</sub>1.2 activity, leading to greater axonal injury and energy consumption (<xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>). These changes were noted in both sexes but were most prominent in male mice (<xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>). The p.A263V variant also exacerbated neurodegeneration associated with multiple sclerosis (<xref rid="R20" ref-type="bibr">Fazeli et al., 2016</xref>).</p><p id="P36">The other existing GOF model emulating a human variant is the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q/+</italic></sup> mouse (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). The <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q/+</italic></sup> mouse was generated by inserting the point mutation p.1883Q into exon 26 of the <italic toggle="yes">Scn2a</italic> gene. These mice displayed phenotypes consistent with developmental epileptic encephalopathy and were not viable after P30 due to frequent seizure activity (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). Overall, <italic toggle="yes">Scn2a</italic> GOF mice have similar seizure phenotypes regardless of the specific mutation. This parallels patient data, as seizure severity is poorly predicted from simply identifying the pathogenic <italic toggle="yes">SCN2A</italic> variant (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>; <xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>, <xref rid="R9" ref-type="bibr">2009</xref>; <xref rid="R15" ref-type="bibr">Crawford et al., 2021</xref>; <xref rid="R39" ref-type="bibr">Lauxmann et al., 2018</xref>; M. <xref rid="R43" ref-type="bibr">Li et al., 2021</xref>; <xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>).</p></sec></sec><sec id="S13"><title><italic toggle="yes">Scn2a</italic>-p.K1422E</title><p id="P37"><italic toggle="yes">SCN2A</italic>-p.K1422E is a pathogenic <italic toggle="yes">de novo</italic> variant of <italic toggle="yes">SCN2A</italic> located in the Na<sub>v</sub>1.2 channel pore. This variant demonstrates both loss and gain of function characteristics in Nav1.2, which has made it difficult to classify (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>). P.K1422E impairs the ion selectivity filter of the Na<sub>v</sub>1.2 channel, thus allowing other ions besides sodium to enter (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>). This mutation diminishes sodium conductance, which alters repolarization and neuronal firing (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>).</p><p id="P38">The mouse model emulating this <italic toggle="yes">Scn2a</italic> variant has been evaluated from both behavioral and electrophysiological perspectives. <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice exhibit reduced anxiety-like behaviors compared to wildtype littermates on the elevated plus maze. However, on the open field test, anxiety-like behaviors are more pronounced in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> female mice compared to wildtype. <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice also display hypersocial behaviors that may parallel what is seen in humans. These mice also do not have impairments in odor discrimination similar to other <italic toggle="yes">Scn2a</italic> haploinsufficient mice (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>; <xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>; <xref rid="R47" ref-type="bibr">Marcantonio et al., 2023</xref>). However, <italic toggle="yes">Scn2a</italic> mutant mice with extremely low levels of <italic toggle="yes">Scn2a</italic> expression or no <italic toggle="yes">Scn2a</italic> expression in ObGCs are slower to discriminate odors (<xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>; <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). These findings indicate that there is a level of <italic toggle="yes">Scn2a</italic> that is required for accurate and efficient olfaction.</p><p id="P39"><italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> cortical neurons revealed slower action potential initiation, likely due to reduced sodium currents (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>). Similar characteristics have been identified in immature cultured cortical neurons from other <italic toggle="yes">Scn2a</italic> haploinsufficient models (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). In vivo EEG recordings of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice displayed infrequent and spontaneous seizures localized to the posterior cortex. When seizures were induced with flurothyl, <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice had a slower progression from myoclonic jerks to generalized tonic-clonic seizures (GTCS) compared to wildtype C57BL/6J littermates. Furthermore, the p.K1422E mutation was found to disrupt the estrous cycle in female mice but did not significantly alter the distribution of GTCS onset in female mice (<xref rid="R19" ref-type="bibr">Echevarria-Cooper &amp; Kearney, 2023</xref>).</p><p id="P40">Similar to some GOF models, the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice demonstrate strain-dependent neurobehavioral and seizure phenotypes (<xref rid="R17" ref-type="bibr">Echevarria-Cooper et al., 2023</xref>). The mouse line was originally generated on the C57BL/6J (B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup>) background but was later crossed with DBA/2J (D2) mice to create a mixed background of [D2xB6], resulting in F1D2.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> animals (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>, <xref rid="R17" ref-type="bibr">2023</xref>). These studies revealed that anxiety-like behaviors are more pronounced in the B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice (<xref rid="R17" ref-type="bibr">Echevarria-Cooper et al., 2023</xref>). F1D2.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice had a seizure profile similar to that of the original B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup>, however, a small subset displayed erratic behavior and then behavioral arrest (<xref rid="R17" ref-type="bibr">Echevarria-Cooper et al., 2023</xref>). Both B6.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> and F1D2.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> resisted seizure generalization with kainic acid, but the resistance was more pronounced in the F1D2.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice (<xref rid="R17" ref-type="bibr">Echevarria-Cooper et al., 2023</xref>). Furthermore, zero of the F1D2.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice reached stage 6 of the Racine scale (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>, <xref rid="R17" ref-type="bibr">2023</xref>). Results from the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">E/+</italic></sup> mice highlight how <italic toggle="yes">Scn2a</italic> variants can present with characteristics of both gain and loss of function, and <italic toggle="yes">SCN2A</italic>-related disorders are likely much more complicated than the variants&#8217; channel kinetics.</p></sec><sec id="S14"><title>Scn2a Mice and Potassium Channels</title><p id="P41">The voltage-gated potassium channel, K<sub>v</sub>7.2, has been shown to contribute to seizure phenotypes seen in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice (<xref rid="R32" ref-type="bibr">Kearney et al., 2006</xref>). This potassium channel generates M currents that modulate hippocampal neurons&#8217; firing pattern and excitability (<xref rid="R32" ref-type="bibr">Kearney et al., 2006</xref>). When Scn2a<sup>Q54</sup> mice also have a mutation in Kv7.2, which reduces the function and activity of the potassium channel, seizure severity of the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice is exacerbated and premature death occurs around P21 (<xref rid="R32" ref-type="bibr">Kearney et al., 2006</xref>). The intense seizure phenotype of the double mutant mice suggests that M currents play an important and likely necessary role in modulating seizure initiation and spreading (<xref rid="R2" ref-type="bibr">Aiba &amp; Noebels, 2021</xref>). Knowing that M currents can regulate seizure severity in an <italic toggle="yes">Scn2a</italic> mouse model opens the possibility of developing a treatment targeting K<sub>v</sub>7.2 to alleviate <italic toggle="yes">SCN2A</italic>-related seizures.</p><p id="P42">Potassium channels also modulate <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> phenotypes (<xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>; <xref rid="R50" ref-type="bibr">Mishra et al., 2017</xref>). Mice heterozygous for both <italic toggle="yes">Scn2a</italic> and <italic toggle="yes">Kcn1,</italic> a gene encoding for the pore-forming subunit of the voltage-gated potassium channel K<sub>V</sub>1.1<italic toggle="yes">(Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>;<italic toggle="yes">Kcna1</italic><sup><italic toggle="yes">+/&#8722;</italic></sup>), have reduced anxiety and autism-like behaviors compared to <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice (<xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>). In addition, the downregulation of potassium channels was found to contribute to the hyperexcitability of medium spiny neurons cultured from <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">gtKO/gtKO</italic></sup> mice (<xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). When pimaric acid, a global potassium channel agonist, was applied to <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">gtKO/gtKO</italic></sup> medium spiny neurons, their excitability was largely normalized to that of wildtype animals (<xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Furthermore, the application of 4-trifluoromethyl-L-phenylglycine, a specific K<sub>v</sub>1.1 agonist, improved the hyperexcitability phenotype of <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">gtKO/gtKO</italic></sup> medium spiny neurons, which indicates that K<sub>v</sub>1.1 may be a potential target for the treatment of some <italic toggle="yes">SCN2A</italic> related seizures (<xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Additionally, <italic toggle="yes">Scn2a</italic> deletion improved the survival of <italic toggle="yes">Kcna1</italic><sup><italic toggle="yes">&#8722;/&#8722;</italic></sup> mice (<xref rid="R50" ref-type="bibr">Mishra et al., 2017</xref>). Lastly, RNA sequencing data from <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">gtKO/gtKO</italic></sup> whole mouse brains indicate that multiple voltage-gated potassium channels are downregulated in response to the loss of Na<sub>v</sub>1.2 (<xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Taken together, these data indicate that Na<sub>v</sub>1.2 and voltage-gated potassium channels likely have a dynamic relationship that may prove useful from a therapeutic perspective.</p><p id="P43">As evidenced by the growing literature of <italic toggle="yes">Scn2a</italic> mouse models, voltage-gated potassium channels are likely important in <italic toggle="yes">SCN2A</italic>-related disorders. Thus far, K<sub>v</sub>1.1, K<sub>v</sub>1.2, K<sub>v</sub>7.2, K<sub>v</sub>8.2, and K<sub>v</sub>9.2 have all been implicated in modulating Na<sub>v</sub>1.2 channel activity and/or expression (<xref rid="R9" ref-type="bibr">Bergren et al., 2009</xref>; <xref rid="R28" ref-type="bibr">Indumathy et al., 2021</xref>; <xref rid="R32" ref-type="bibr">Kearney et al., 2006</xref>; <xref rid="R50" ref-type="bibr">Mishra et al., 2017</xref>; <xref rid="R55" ref-type="bibr">Nadella et al., 2022</xref>; <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Potassium channel modulation should continue to be explored as a therapeutic target for the seizure treatment of individuals with pathogenic <italic toggle="yes">SCN2A</italic> variants (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>; <xref rid="R39" ref-type="bibr">Lauxmann et al., 2018</xref>). However, it is important to note that the decision to block or activate specific potassium channels to attenuate seizures would likely depend on each patient&#8217;s specific variant.</p></sec><sec id="S15"><title>Treatment of <italic toggle="yes">Scn2a</italic> Related Phenotypes in Mice</title><sec id="S16"><title>Genetic Rescue</title><p id="P44">There have been multiple attempts to develop a viable and safe genetic therapy to alleviate <italic toggle="yes">SCN2A</italic>-related disorders. One such attempt explored <italic toggle="yes">cis</italic>-regulation therapy (CRT) by using a dCas9 fused to a transcriptional co-activator (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). This method allows CRISPR activation (CRISPRa) to increase the expression of the functional wildtype <italic toggle="yes">Scn2a</italic> allele in both <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/kl</italic></sup> mice (<xref rid="SD1" ref-type="supplementary-material">Supplemental Table 1</xref>) (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). The rAAV-CRISPRa-based treatment restored typical excitability patterns in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> cortical neurons compared to wildtype (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). Furthermore, the treatment was not shown to induce seizures or lead to phenotypic abnormalities in the animals (<xref rid="R78" ref-type="bibr">Tamura et al., 2022</xref>). CRISPRa rescue and upregulation of <italic toggle="yes">Scn2a</italic> was then utilized to recover an appropriate vestibular ocular reflex (VOR) in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice which is known to be impaired in both humans with pathogenic variants of <italic toggle="yes">SCN2A</italic> and <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice (<xref rid="R84" ref-type="bibr">C. Wang et al., 2024</xref>). Based on the promising results from the mouse models, it appears that using CRISPRa therapy could be a viable and safe avenue for treating <italic toggle="yes">SCN2A</italic> loss-of-function variants. Further data indicating the safety and efficacy of the CRISPRa treatment will be needed to truly know if this is an avenue of treatment that will benefit individuals like it appears to benefit the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice.</p><p id="P45">Another genetic therapy approach involves gapmer antisense oligonucleotides (ASO), which target <italic toggle="yes">Scn2a</italic> mRNA (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). The ASO was developed to alleviate seizures experienced by <italic toggle="yes">Scn2a</italic><sup>Q/+</sup> mice (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). Two doses of the ASO ED were tested: ASO ED50 and ED80, which reduced <italic toggle="yes">Scn2a</italic> mRNA by 50% and 80%, respectively. ASO ED80 was found to be toxic in wildtype C57BL/6N mice, although it did extend the lifespan of <italic toggle="yes">Scn2a</italic><sup>Q/+</sup> mice and attenuated seizure severity when utilized at P1 (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). On the other hand, ASO ED50, when used at P1, did not impair weight, sociability, or motor behavior in wildtype C57BL/6N mice or <italic toggle="yes">Scn2a</italic><sup>Q/+</sup> mice (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). However, ASO ED50 did reduce anxiety-like behaviors in <italic toggle="yes">Scn2a</italic><sup>Q/+</sup> mice below what was seen in treated wildtype C57BL/6N mice (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). Treating <italic toggle="yes">Scn2a</italic><sup>Q/+</sup> mice older than P1 with ASO ED50 still attenuated seizure severity and extended lifespan compared to untreated animals, which suggests some degree of flexibility in the treatment window (<xref rid="R43" ref-type="bibr">M. Li et al., 2021</xref>). From the reported data, it seems plausible that ASO therapy may benefit some <italic toggle="yes">SCN2A</italic> variants. However, ASO therapies need to be tailored to specific variants to be effective, and the heterogeneous nature of <italic toggle="yes">SCN2A</italic> reduces the possibility of generating a large-scale treatment of <italic toggle="yes">SCN2A</italic>-related disorders utilizing this approach (<xref rid="R38" ref-type="bibr">Lauffer et al., 2024</xref>). Furthermore, Tofersen, the only FDA-approved ASO, is associated with many adverse side effects and has demonstrated limited therapeutic benefit (<xref rid="R38" ref-type="bibr">Lauffer et al., 2024</xref>). Treatments utilized in <italic toggle="yes">SCN2A</italic>-related disorders must be safe and effective as it is likely to be provided to children, and aversive side effects may irreversibly alter development.</p></sec><sec id="S17"><title>Drug Treatment</title><p id="P46">Several pharmacotherapies have been tried in <italic toggle="yes">Scn2a</italic> mouse models to attenuate symptoms associated with pathogenic variants. One such drug is CX516, a positive allosteric modulator of AMPA receptors (<xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>). Intraperitoneal injection of CX516 at least 10 minutes prior to behavioral tasks at multiple doses was shown to reduce hyperactivity phenotypes seen in <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice (<xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>). The greatest effect was seen at the highest dose, 40 mg/kg<sub>,</sub> and the treatment did not appear to negatively affect wildtype C57BL/6J mice (<xref rid="R79" ref-type="bibr">Tatsukawa et al., 2019</xref>).</p><p id="P47">Other drugs tested in <italic toggle="yes">Scn2a</italic> mutant mice have been utilized to attenuate seizures. These drugs include Ranolazine and GS967/ PRAX-562, which both inhibit persistent sodium current (<xref rid="R3" ref-type="bibr">Anderson et al., 2014</xref>). Both of these drugs reduced seizure frequency in F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice with GS967/ PRAX-562 being more effective (<xref rid="R3" ref-type="bibr">Anderson et al., 2014</xref>). GS967/ PRAX-562 further improved survival of F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice and prevented hilar neuron loss and protected the mice from induced seizures in the maximal electroshock paradigm (<xref rid="R3" ref-type="bibr">Anderson et al., 2014</xref>). However, GS967/ PRAX-562 suppressed hippocampal mossy fiber sprouting in these mice, which could lead to the alteration of behavioral phenotypes, like spatial learning (<xref rid="R14" ref-type="bibr">Comba et al., 2015</xref>; <xref rid="R64" ref-type="bibr">Ram&#237;rez-Amaya et al., 2001</xref>). Further data from mice treated with GS967/ PRAX-562 are needed to evaluate potential adverse effects. Although these sodium channel blockers are effective in treating the GOF seizure phenotype of F1.<italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">Q54</italic></sup> mice, they would likely be an ineffective, if not harmful, treatment of seizures for individuals with LOF <italic toggle="yes">SCN2A</italic> variants (<xref rid="R34" ref-type="bibr">H. J. Kim et al., 2020</xref>; <xref rid="R48" ref-type="bibr">Miao et al., 2020</xref>; <xref rid="R61" ref-type="bibr">Oyrer et al., 2018</xref>; <xref rid="R65" ref-type="bibr">Reynolds et al., 2020</xref>; <xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>).</p></sec></sec><sec id="S18"><title>Other Rodent Models of <italic toggle="yes">Scn2a</italic></title><p id="P48">Research performed in rats established our foundational understanding of <italic toggle="yes">SCN2A,</italic> like the temporal patterning of <italic toggle="yes">SCN2A</italic> expression (<xref rid="R24" ref-type="bibr">Gong et al., 1999</xref>) and the subcellular localization of Na<sub>v</sub>1.2 (<xref rid="R87" ref-type="bibr">Westenbroek et al., 1989</xref>). In Sprague Dawley rats, Na<sub>v</sub>1.2 protein is expressed within the forebrain, substantia nigra, hippocampus, and the molecular and granular layers of the cerebellum (<xref rid="R87" ref-type="bibr">Westenbroek et al., 1989</xref>) while Na<sub>v</sub>1.2 mRNA was highly expressed within the pyramidal and granule layer of the dentate gyrus as well as the granule layer of the cerebellum (<xref rid="R10" ref-type="bibr">Black et al., 1994</xref>). Na<sub>v</sub>1.2 was further found to have a complementary expression pattern with Na<sub>v</sub>1.1 throughout the rat cortex and preferentially localized to axons (<xref rid="R24" ref-type="bibr">Gong et al., 1999</xref>). Further background work utilizing Sprague Dawley rats revealed a population of Na<sub>v</sub>1.2 lacking the beta-2 subunit during the first two weeks of life that was not present in older animals, indicating that <italic toggle="yes">Scn2a</italic> undergoes developmental stage-specific changes (<xref rid="R24" ref-type="bibr">Gong et al., 1999</xref>). Recently, a Long Evans rat <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> model was engineered using CRISPR-Cas9 to disrupt exon 5 of <italic toggle="yes">Scn2a</italic> (<xref rid="R30" ref-type="bibr">Kastner et al., 2024</xref>), which generates a frameshift and presumed LOF. On a novel choice-wide behavioral association test, the <italic toggle="yes">Scn2a</italic>
<sup><italic toggle="yes">+/&#8722;</italic></sup> rats displayed impairments in spatial alternation-related behaviors compared to wildtype controls (<xref rid="R30" ref-type="bibr">Kastner et al., 2024</xref>).</p><p id="P49">Currently, an <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> prairie vole is being characterized (Perry Spratt 2020). Prairie voles have social structures more similar to humans than rats or mice and may better emulate the social changes seen in human <italic toggle="yes">SCN2A</italic> disorders. The <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> prairie vole model is being engineered using CRISPR-Cas9 mutagenesis to introduce a premature stop codon within the first and third coding exons of the <italic toggle="yes">Scn2a</italic> gene (Perry Spratt 2020). Preliminary data from the early generations of the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> prairie voles indicate impaired dendritic excitability similar to the <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mouse models (Perry Spratt 2020). This may be the first evidence that dendritic deficits caused by loss of <italic toggle="yes">Scn2a</italic> are conserved across species.</p></sec></sec><sec id="S19"><title>Discussion</title><sec id="S20"><title>Why are there Differential Findings in <italic toggle="yes">Scn2a</italic> Rodent Models?</title><p id="P50">Loss of Na<sub>v</sub>1.2 leads to many changes in neuronal activity that can be specific to cell type and developmental stage. Severe loss of Na<sub>v</sub>1.2 can lead to paradoxical increases in the excitability of mature cortical-striatal and neocortical pyramidal neurons while also impairing dendritic excitability (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>; <xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>; <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). Nevertheless, loss of Na<sub>v</sub>1.2 in immature <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> pyramidal neurons leads to reduced excitability similar to the effects seen in obGCs and somatosensory cortical neurons (<xref rid="R42" ref-type="bibr">M. Li et al., 2023</xref>; <xref rid="R57" ref-type="bibr">Nunes &amp; Kuner, 2018</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>). Since distinct brain regions and cell types differentially contribute to many behaviors, and the functional impact of Na<sub>v</sub>1.2 loss differs based on neuronal cell type and developmental stage, this could be a source of apparently conflicting findings in <italic toggle="yes">SCN2A</italic> models. When conducting behavioral assays in <italic toggle="yes">Scn2a</italic> mutant mice, it is important to consider what cell type or brain region is involved in the behavior being assessed since the functional role of <italic toggle="yes">SCN2A</italic> may be variable across paradigms. It is also paramount that when electrophysical consequences of Na<sub>v</sub>1.2 loss are investigated, the developmental stage and cell type are reported, as that information can drastically change interpretation of results.</p><p id="P51">Another factor that could contribute to the inconsistent behavioral findings is the age of the mice being tested. At least one study to date found that behavioral phenotypes attenuate as <italic toggle="yes">Scn2a</italic><sup><italic toggle="yes">+/&#8722;</italic></sup> mice age, and multiple studies have identified electrophysiological alterations that are only present during the first postnatal week (<xref rid="R40" ref-type="bibr">L&#233;na &amp; Mantegazza, 2019</xref>; <xref rid="R59" ref-type="bibr">Ogiwara et al., 2018</xref>; <xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>). Na<sub>v</sub>1.2 is known to play a significant role in adult animal&#8217;s excitatory neurons but may also influence inhibitory neurons early in development (<xref rid="R52" ref-type="bibr">Miyamoto et al., 2019</xref>). Moreover, there are two isoforms of Na<sub>v</sub>1.2: the neonatal and adult. The neonatal isoform of Na<sub>v</sub>1.2 is less excitable than the adult isoform and is replaced by the adult isoform starting around P9 in mice (<xref rid="R23" ref-type="bibr">Gazina et al., 2010</xref>; <xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). Some <italic toggle="yes">SCN2A</italic> variants exhibit greater and more severe dysfunction in the neonatal isoform than the adult (<xref rid="R53" ref-type="bibr">Muller, 2020</xref>; <xref rid="R80" ref-type="bibr">Thompson et al., 2020</xref>;<xref rid="R5" ref-type="bibr">Ben-Shalom et al., 2017</xref>). For example, <italic toggle="yes">SCN2A</italic> variants associated with SeLFNIE exhibit early-onset seizures that remit within the first few years of life (<xref rid="R90" ref-type="bibr">Xu et al., 2007</xref>). These findings support the idea that the two isoforms of <italic toggle="yes">SCN2A</italic> have different roles in neuronal excitability and could differentially contribute to observed phenotypes. Therefore, it is reasonable to suggest that variation in the ages of the <italic toggle="yes">Scn2a</italic> mutant mice evaluated for behavior may contribute to some of the differential findings. To determine the full developmental and functional impact of Na<sub>v</sub>1.2 variants, regardless of isoform, <italic toggle="yes">SCN2A</italic> models should be explored from a developmental perspective, and results should be reported with those details.</p><p id="P52">It is key to note that <italic toggle="yes">SCN2A</italic> is not a sex-linked gene, and therefore disorders secondary to <italic toggle="yes">SCN2A</italic> mutations have an equal likelihood of occurring in both males and females at similar rates. However, <italic toggle="yes">SCN2A</italic> variants could interact with sex-dependent genes and hormones differently. For instance, the p.K1422E variant was found to disrupt the estrous cycle of female mice, which could lead to different behavioral phenotypes between male and female mice (<xref rid="R19" ref-type="bibr">Echevarria-Cooper &amp; Kearney, 2023</xref>). Without accounting for hormonal cycles, multiple investigations of <italic toggle="yes">Scn2a</italic> mice have already noted behavioral differences between male and female mice (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>; <xref rid="R47" ref-type="bibr">Marcantonio et al., 2023</xref>; <xref rid="R68" ref-type="bibr">Schattling et al., 2016</xref>; <xref rid="R73" ref-type="bibr">Spratt et al., 2019</xref>, <xref rid="R72" ref-type="bibr">2021</xref>). Thus, it is paramount that <italic toggle="yes">SCN2A</italic>-related disorders continue to be equally investigated in male and female animals, as sex differences could create differences in the presentation of symptoms.</p><p id="P53">Lastly, the background strain of the animals themselves likely contributes to the contrasting behavioral results between similar <italic toggle="yes">Scn2a</italic> models. In work with GOF <italic toggle="yes">Scn2a</italic> models the genetic background strain has been shown to alter the severity of displayed phenotypes (<xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>; <xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>). Experiments completed with different genetic strains highlight the importance of considering both genetic and epigenetic modifiers when thinking about how <italic toggle="yes">Scn2a</italic> variants lead to disease. It has yet to be determined which background strain most accurately and reliably recapitulates human symptomatology of <italic toggle="yes">Scn2a</italic>-related disorders.</p></sec><sec id="S21"><title>Gain and Loss of Function Classification of <italic toggle="yes">SCN2A</italic> mutations; is it Enough?</title><p id="P54"><italic toggle="yes">SCN2A-</italic>related disorders can drastically change a child&#8217;s quality of life; therefore, it is imperative to determine the varying pathologies and prognoses enumerated by <italic toggle="yes">SCN2A</italic> variants. Currently, it is thought that <italic toggle="yes">SCN2A-</italic>related disorders bifurcate into two categories: neurodevelopmental disorders caused by LOF or seizure disorders caused by GOF in Na<sub>v</sub>1.2. GOF mutations often result in early-onset seizure disorders (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>; <xref rid="R39" ref-type="bibr">Lauxmann et al., 2018</xref>), while LOF mutations are linked to diagnoses of Autism Spectrum Disorder (ASD) and/or intellectual disability (ID) and other neuropsychiatric conditions (<xref rid="R5" ref-type="bibr">Ben-Shalom et al., 2017</xref>). While this binary organization has simplified the classification of Na<sub>v</sub>1.2 channel function, it does not fully capture the nuances of <italic toggle="yes">SCN2A</italic>-related disorders.</p><p id="P55">Although LOF variants are largely associated with ASD and ID, an estimated 30% of individuals with LOF mutations develop severe seizure disorders that are often intractable (<xref rid="R65" ref-type="bibr">Reynolds et al., 2020</xref>; <xref rid="R80" ref-type="bibr">Thompson et al., 2020</xref>). Data from LOF <italic toggle="yes">SCN2A</italic> models indicate that compensatory and maladaptive changes in potassium channels can lead to the onset of seizures (<xref rid="R72" ref-type="bibr">Spratt et al., 2021</xref>; <xref rid="R93" ref-type="bibr">Zhang et al., 2021</xref>). There are also LOF variants that lead to the development of seizures prior to 3 months of age in humans, including p.R853Q,p.G899S, and p.P1658S (<xref rid="R6" ref-type="bibr">Berecki et al., 2018</xref>; <xref rid="R48" ref-type="bibr">Miao et al., 2020</xref>; <xref rid="R88" ref-type="bibr">Wolff et al., 2017</xref>). As the age of seizure onset does not always align with the true electrophysical profile of the channel variant, (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>)) argued that it should not be the sole classifier of an <italic toggle="yes">SCN2A</italic> channel variant. Furthermore, misassignment of the GOF or LOF label to a <italic toggle="yes">SCN2A</italic> channel variant can be detrimental as treatment of a LOF variant with sodium channel blockers can exacerbate seizures and lead to unfavorable outcomes for the affected individual (<xref rid="R48" ref-type="bibr">Miao et al., 2020</xref>; <xref rid="R61" ref-type="bibr">Oyrer et al., 2018</xref>, p. 8; <xref rid="R65" ref-type="bibr">Reynolds et al., 2020</xref>; <xref rid="R80" ref-type="bibr">Thompson et al., 2020</xref>). Additionally, the age of onset and the electrophysical properties of <italic toggle="yes">SCN2A</italic> GOF channel variants are poor predictors of severity of seizures, suggesting we should seek better biomarkers of disease progression and severity (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>; <xref rid="R15" ref-type="bibr">Crawford et al., 2021</xref>; <xref rid="R39" ref-type="bibr">Lauxmann et al., 2018</xref>).</p><p id="P56">Human data also indicate that identical channel variants can lead to different phenotypes and diagnoses across individuals (<xref rid="R7" ref-type="bibr">Berecki et al., 2022</xref>; <xref rid="R62" ref-type="bibr">Passi &amp; Mohammad, 2021</xref>). For instance, the autosomal dominant <italic toggle="yes">SCN2A</italic> variant p.L1650P presented in a male child as episodic ataxia but in the father as episodic hemiplegia, two very distinct diagnoses (<xref rid="R62" ref-type="bibr">Passi &amp; Mohammad, 2021</xref>). Similarly, the variants p.R1319Q and p.V261M lead to severe developmental delay in some individuals, while others with the variants have typical development (<xref rid="R92" ref-type="bibr">Zeng et al., 2022</xref>). Likewise, the variants p.R102X and p.R1435X led to seizures in some individuals but no seizures in others (<xref rid="R4" ref-type="bibr">Begemann et al., 2019</xref>; <xref rid="R29" ref-type="bibr">Kamiya et al., 2004</xref>; <xref rid="R83" ref-type="bibr">Trump et al., 2016</xref>; <xref rid="R88" ref-type="bibr">Wolff et al., 2017</xref>). Currently, it is unclear what drives the differences between individuals with identical channel variants, but it is clear that the consequences of channel variants are not fully explained by the variants themselves. Patients with similar or identical pathogenic variants should undergo whole genome and/or epigenome sequencing as their unique genetic and epigenetic profiles could explain at least in part their dissimilar symptomology. Data from <italic toggle="yes">Scn2a</italic> mouse models support the idea that genetic modifiers can drive symptom presentation and severity, but genetic modifiers have not been explored in humans (<xref rid="R8" ref-type="bibr">Bergren et al., 2005</xref>, <xref rid="R9" ref-type="bibr">2009</xref>; <xref rid="R11" ref-type="bibr">Calhoun et al., 2016</xref>; <xref rid="R26" ref-type="bibr">Hawkins &amp; Kearney, 2016</xref>; <xref rid="R46" ref-type="bibr">MacDonald et al., 2004</xref>; <xref rid="R62" ref-type="bibr">Passi &amp; Mohammad, 2021</xref>; <xref rid="R81" ref-type="bibr">Thompson et al., 2017</xref>).</p><p id="P57">There are also now reports of <italic toggle="yes">SCN2A</italic> variants displaying both GOF and LOF characteristics, defying categorization by the binary system. For instance, the p.K1422E variant located on the channel pore of Na<sub>v</sub>1.2 displays mixed biophysical characteristics to the extent that the authors who originally characterized the variant were not comfortable assigning it a classification (<xref rid="R18" ref-type="bibr">Echevarria-Cooper et al., 2022</xref>). Another variant, p.G879R, was found to have a largely LOF profile but with an increased degree of overlap between the activation and inactivation of sodium channel currents typical of a GOF channel variant (<xref rid="R91" ref-type="bibr">Yang et al., 2022</xref>). The biophysical profile of a channel variant can also shift depending on the <italic toggle="yes">SCN2A</italic> isoform present, like in the case of p.R1882L and p.R1882Q (<xref rid="R82" ref-type="bibr">Thompson et al., 2023</xref>). Both variants display GOF characteristics while neonatal Na<sub>v</sub>1.2 is expressed but display mixed biophysical properties when the adult isoform replaces the neonatal (<xref rid="R82" ref-type="bibr">Thompson et al., 2023</xref>). Data from individuals with <italic toggle="yes">SCN2A</italic>-related disorders, SeLFNIE (previously BFNIS), further highlight the influence that <italic toggle="yes">SCN2A</italic> isoforms have on pathogenic variant symptom presentation (<xref rid="R90" ref-type="bibr">Xu et al., 2007</xref>). These individuals usually experience typical development and display early-onset seizures that attenuate with age (<xref rid="R90" ref-type="bibr">Xu et al., 2007</xref>). From non-human mammalian models, we can garner that this is likely due to the different electrophysical properties of the neonatal and adult channel isoforms (<xref rid="R22" ref-type="bibr">Gazina et al., 2015</xref>). The pathogenic <italic toggle="yes">SCN2A</italic> variants leading to SeLFNIE likely cause the neonatal Na<sub>v</sub>1.2 isoform to behave more like the adult isoform. Therefore, when the adult isoform replaces the neonatal, the biophysical properties of the Na<sub>v</sub>1.2 channel likely better match the developmental state of the individual and attenuate the seizure phenotype. These data demonstrate the need to study the developmental effects and trajectory of the <italic toggle="yes">SCN2A</italic> gene and its variants.</p><p id="P58">A recent study utilized human phenotype ontology terms to evaluate potential correlations between diagnostic terms and <italic toggle="yes">SCN2A</italic> variants (<xref rid="R15" ref-type="bibr">Crawford et al., 2021</xref>). The analysis revealed that missense <italic toggle="yes">SCN2A</italic> variants are largely correlated with terms like &#8220;neonatal onset,&#8221; &#8220;seizures,&#8217; and &#8220;no intellectual disability&#8221;, while premature termination variants were correlated with terms like &#8220;behavioral abnormality,&#8221; &#8220;autism,&#8221; &#8220;autistic behavior,&#8221; and &#8220; no seizures&#8217;&#8217; (<xref rid="R15" ref-type="bibr">Crawford et al., 2021</xref>). Although ASD and ID diagnoses are primarily associated with premature termination variants, these diagnoses can still be related to missense <italic toggle="yes">SCN2A</italic> variants. Furthermore, if seizures, developmental delay (DD), or intellectual disability (ID) are profound, it can be impossible to disentangle symptoms of autism spectrum disorder (ASD) from existing comorbidities, so the diagnosis is not made (<xref rid="R74" ref-type="bibr">Srivastava &amp; Sahin, 2017</xref>). There is at least one reported variant, p.L1342P, where the patient presented with ID and early seizure onset but also displayed no eye contact, which is a common trait of ASD (<xref rid="R4" ref-type="bibr">Begemann et al., 2019</xref>). It is possible that the comorbidities of existing diagnoses masked a potential diagnosis of ASD (<xref rid="R74" ref-type="bibr">Srivastava &amp; Sahin, 2017</xref>).</p><p id="P59">The phrase &#8220;When you hear hoof beats, don&#8217;t look for zebras&#8221; is often used in medicine to encourage providers to look for common diagnoses, but <italic toggle="yes">SCN2A</italic>-related disorders are not common; each variant produces a unique profile of symptoms. Understanding whether a variant is gain-of-function (GOF) or loss-of-function (LOF) can guide initial treatment, but it is unlikely to capture the complete biophysical and symptom profile of every individual. <italic toggle="yes">SCN2A</italic>-related disorders do not occur within a binary but a spectrum of diagnoses, and the biophysical characteristics of channel variants are likely just as complex.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data" orientation="portrait"><label>Supplement 1</label><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="NIHPP2411.10421v1-supplement-1.pdf" id="d67e3481" position="anchor" orientation="portrait"/></supplementary-material></sec></body><back><ack id="S22"><title>Acknowledgements:</title><p id="P60">This work was supported by iDREAM (R25 NS130966) to MFHA, the Neuroscience Graduate Program T32 (T32 NS007421) (KS), and the Department of Defense Autism Research Program (DOD AR220030) (AJW).</p></ack><ref-list><title>References</title><ref id="R1"><mixed-citation publication-type="journal"><name name-style="western"><surname>Adney</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Millichap</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>DeKeyser</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Abramova</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2020</year>). <article-title>Functional and pharmacological evaluation of a novel SCN2A variant linked to early-onset epilepsy</article-title>. <source>Annals of Clinical and Translational Neurology</source>, <volume>7</volume>(<issue>9</issue>), <fpage>1488</fpage>&#8211;<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.51105</pub-id><pub-id pub-id-type="pmid">32750235</pub-id><pub-id pub-id-type="pmcid">PMC7480906</pub-id></mixed-citation></ref><ref id="R2"><mixed-citation publication-type="journal"><name name-style="western"><surname>Aiba</surname><given-names>I.</given-names></name>, &amp; <name name-style="western"><surname>Noebels</surname><given-names>J. L.</given-names></name> (<year>2021</year>). <article-title>Kcnq2/Kv7.2 controls the threshold and bi-hemispheric symmetry of cortical spreading depolarization</article-title>. <source>Brain</source>, <volume>144</volume>(<issue>9</issue>), <fpage>2863</fpage>&#8211;<lpage>2878</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awab141</pub-id><pub-id pub-id-type="pmid">33768249</pub-id><pub-id pub-id-type="pmcid">PMC8536937</pub-id></mixed-citation></ref><ref id="R3"><mixed-citation publication-type="journal"><name name-style="western"><surname>Anderson</surname><given-names>L. L.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, <name name-style="western"><surname>Nath</surname><given-names>R. D.</given-names></name>, <name name-style="western"><surname>Petersohn</surname><given-names>A. A.</given-names></name>, <name name-style="western"><surname>Rajamani</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bush</surname><given-names>W. S.</given-names></name>, <name name-style="western"><surname>Frankel</surname><given-names>W. N.</given-names></name>, <name name-style="western"><surname>Vanoye</surname><given-names>C. G.</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2014</year>). <article-title>Antiepileptic activity of preferential inhibitors of persistent sodium current</article-title>. <source>Epilepsia</source>, <volume>55</volume>(<issue>8</issue>), <fpage>1274</fpage>&#8211;<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12657</pub-id><pub-id pub-id-type="pmid">24862204</pub-id><pub-id pub-id-type="pmcid">PMC4126848</pub-id></mixed-citation></ref><ref id="R4"><mixed-citation publication-type="journal"><name name-style="western"><surname>Begemann</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Acu&#241;a</surname><given-names>M. A.</given-names></name>, <name name-style="western"><surname>Zweier</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Vincent</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Steindl</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Bachmann-Gagescu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hackenberg</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Abela</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Plecko</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kroell-Seger</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Baumer</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Asadollahi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sticht</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zeilhofer</surname><given-names>H. U.</given-names></name>, &amp; <name name-style="western"><surname>Rauch</surname><given-names>A.</given-names></name> (<year>2019</year>). <article-title>Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes</article-title>. <source>Molecular Medicine</source>, <volume>25</volume>(<issue>1</issue>), <fpage>6</fpage>. <pub-id pub-id-type="doi">10.1186/s10020-019-0073-6</pub-id><pub-id pub-id-type="pmid">30813884</pub-id><pub-id pub-id-type="pmcid">PMC6391808</pub-id></mixed-citation></ref><ref id="R5"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Keeshen</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Berrios</surname><given-names>K. N.</given-names></name>, <name name-style="western"><surname>An</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2017</year>). <article-title>Opposing Effects on NaV1.2 Function Underlie Differences Between SCN2A Variants Observed in Individuals With Autism Spectrum Disorder or Infantile Seizures</article-title>. <source>Biological Psychiatry</source>, <volume>82</volume>(<issue>3</issue>), <fpage>224</fpage>&#8211;<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.biopsych.2017.01.009</pub-id><pub-id pub-id-type="pmid">28256214</pub-id><pub-id pub-id-type="pmcid">PMC5796785</pub-id></mixed-citation></ref><ref id="R6"><mixed-citation publication-type="journal"><name name-style="western"><surname>Berecki</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Howell</surname><given-names>K. B.</given-names></name>, <name name-style="western"><surname>Deerasooriya</surname><given-names>Y. H.</given-names></name>, <name name-style="western"><surname>Cilio</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Oliva</surname><given-names>M. K.</given-names></name>, <name name-style="western"><surname>Kaplan</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Scheffer</surname><given-names>I. E.</given-names></name>, <name name-style="western"><surname>Berkovic</surname><given-names>S. F.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2018</year>). <article-title>Dynamic action potential clamp predicts functional separation in mild familial and severe de novo forms of <italic toggle="yes">SCN2A</italic> epilepsy</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>115</volume>(<issue>24</issue>). <pub-id pub-id-type="doi">10.1073/pnas.1800077115</pub-id><pub-id pub-id-type="pmcid">PMC6004444</pub-id><pub-id pub-id-type="pmid">29844171</pub-id></mixed-citation></ref><ref id="R7"><mixed-citation publication-type="journal"><name name-style="western"><surname>Berecki</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Howell</surname><given-names>K. B.</given-names></name>, <name name-style="western"><surname>Heighway</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Olivier</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Rodda</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Overmars</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Vlaskamp</surname><given-names>D. R. M.</given-names></name>, <name name-style="western"><surname>Ware</surname><given-names>T. L.</given-names></name>, <name name-style="western"><surname>Ardern-Holmes</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lesca</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Alber</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Veggiotti</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Scheffer</surname><given-names>I. E.</given-names></name>, <name name-style="western"><surname>Berkovic</surname><given-names>S. F.</given-names></name>, <name name-style="western"><surname>Wolff</surname><given-names>M.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2022</year>). <article-title>Functional correlates of clinical phenotype and severity in recurrent SCN2A variants</article-title>. <source>Communications Biology</source>, <volume>5</volume>(<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s42003-022-03454-1</pub-id><pub-id pub-id-type="pmid">35637276</pub-id><pub-id pub-id-type="pmcid">PMC9151917</pub-id></mixed-citation></ref><ref id="R8"><mixed-citation publication-type="journal"><name name-style="western"><surname>Bergren</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Galecki</surname><given-names>A.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2005</year>). <article-title>Genetic modifiers affecting severity of epilepsy caused by mutation of sodium channelScn2a</article-title>. <source>Mammalian Genome</source>, <volume>16</volume>(<issue>9</issue>), <fpage>683</fpage>&#8211;<lpage>690</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-005-0049-4</pub-id><pub-id pub-id-type="pmid">16245025</pub-id></mixed-citation></ref><ref id="R9"><mixed-citation publication-type="journal"><name name-style="western"><surname>Bergren</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Rutter</surname><given-names>E. D.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2009</year>). <article-title>Fine Mapping of an Epilepsy Modifier Gene on Mouse Chromosome 19</article-title>. <source>Mammalian Genome : Official Journal of the International Mammalian Genome Society</source>, <volume>20</volume>(<issue>6</issue>), <fpage>359</fpage>&#8211;<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1007/s00335-009-9193-6</pub-id><pub-id pub-id-type="pmid">19513789</pub-id><pub-id pub-id-type="pmcid">PMC2804848</pub-id></mixed-citation></ref><ref id="R10"><mixed-citation publication-type="journal"><name name-style="western"><surname>Black</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Yokoyama</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Higashida</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ransom</surname><given-names>B. R.</given-names></name>, &amp; <name name-style="western"><surname>Waxman</surname><given-names>S. G.</given-names></name> (<year>1994</year>). <article-title>Sodium channel mRNAs I, II and III in the CNS: Cell-specific expression</article-title>. <source>Molecular Brain Research</source>, <volume>22</volume>(<issue>1</issue>), <fpage>275</fpage>&#8211;<lpage>289</lpage>. <pub-id pub-id-type="doi">10.1016/0169-328X(94)90056-6</pub-id><pub-id pub-id-type="pmid">8015385</pub-id></mixed-citation></ref><ref id="R11"><mixed-citation publication-type="journal"><name name-style="western"><surname>Calhoun</surname><given-names>J. D.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, <name name-style="western"><surname>Zachwieja</surname><given-names>N. J.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2016</year>). <article-title>Cacna1g is a genetic modifier of epilepsy caused by mutation of voltage-gated sodium channel Scn2a</article-title>. <source>Epilepsia</source>, <volume>57</volume>(<issue>6</issue>), <fpage>e103</fpage>&#8211;<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13390</pub-id><pub-id pub-id-type="pmid">27112236</pub-id><pub-id pub-id-type="pmcid">PMC4985168</pub-id></mixed-citation></ref><ref id="R12"><mixed-citation publication-type="journal"><name name-style="western"><surname>Carroll</surname><given-names>L. S.</given-names></name>, <name name-style="western"><surname>Woolf</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Dwyer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Walters</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Kirov</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>O&#8217;Donovan</surname><given-names>M. C.</given-names></name>, &amp; <name name-style="western"><surname>Owen</surname><given-names>M. J.</given-names></name> (<year>2016</year>). <article-title>Mutation screening of SCN2A in schizophrenia and identification of a novel loss-of-function mutation</article-title>. <source>Psychiatric Genetics</source>, <volume>26</volume>(<issue>2</issue>), <fpage>60</fpage>. <pub-id pub-id-type="doi">10.1097/YPG.0000000000000110</pub-id><pub-id pub-id-type="pmid">26555645</pub-id><pub-id pub-id-type="pmcid">PMC4756433</pub-id></mixed-citation></ref><ref id="R13"><mixed-citation publication-type="journal"><name name-style="western"><surname>Carson</surname><given-names>T. B.</given-names></name>, <name name-style="western"><surname>Wilkes</surname><given-names>B. J.</given-names></name>, <name name-style="western"><surname>Patel</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Pineda</surname><given-names>J. L.</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Newell</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Bodfish</surname><given-names>J. W.</given-names></name>, <name name-style="western"><surname>Schubert</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Radonovich</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>White</surname><given-names>K. D.</given-names></name>, &amp; <name name-style="western"><surname>Lewis</surname><given-names>M. H.</given-names></name> (<year>2017</year>). <article-title>Vestibulo-ocular reflex function in children with high-functioning autism spectrum disorders</article-title>. <source>Autism Research</source>, <volume>10</volume>(<issue>2</issue>), <fpage>251</fpage>&#8211;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1002/aur.1642</pub-id><pub-id pub-id-type="pmid">27220548</pub-id></mixed-citation></ref><ref id="R14"><mixed-citation publication-type="journal"><name name-style="western"><surname>Comba</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Gervais</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Mumby</surname><given-names>D.</given-names></name>, &amp; <name name-style="western"><surname>Holahan</surname><given-names>M.</given-names></name> (<year>2015</year>). <article-title>Emergence of spatial behavioral function and associated mossy fiber connectivity and c-Fos labeling patterns in the hippocampus of rats</article-title>. <source>F1000Research</source>, <volume>4</volume>, <fpage>396</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.6822.1</pub-id><pub-id pub-id-type="pmid">26925223</pub-id><pub-id pub-id-type="pmcid">PMC4712777</pub-id></mixed-citation></ref><ref id="R15"><mixed-citation publication-type="journal"><name name-style="western"><surname>Crawford</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Xian</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Helbig</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Galer</surname><given-names>P. D.</given-names></name>, <name name-style="western"><surname>Parthasarathy</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lewis-Smith</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kaufman</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>Fitch</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ganesan</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>O&#8217;Brien</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Codoni</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Ellis</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Conway</surname><given-names>L. J.</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Krause</surname><given-names>R.</given-names></name>, &amp; <name name-style="western"><surname>Helbig</surname><given-names>I.</given-names></name> (<year>2021</year>). <article-title>Computational analysis of 10,860 phenotypic annotations in individuals with SCN2A-related disorders</article-title>. <source>Genetics in Medicine</source>, <volume>23</volume>(<issue>7</issue>), <fpage>1263</fpage>&#8211;<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1038/s41436-021-01120-1</pub-id><pub-id pub-id-type="pmid">33731876</pub-id><pub-id pub-id-type="pmcid">PMC8257493</pub-id></mixed-citation></ref><ref id="R16"><mixed-citation publication-type="journal"><name name-style="western"><surname>Eaton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>A. C.</given-names></name>, <name name-style="western"><surname>Lietzke</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Romero</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Coleman</surname><given-names>E. R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Que</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Palant</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nguyen</surname><given-names>H. P.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Skarnes</surname><given-names>W. C.</given-names></name>, <name name-style="western"><surname>Koss</surname><given-names>W. A.</given-names></name>, &amp; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name> (<year>2021</year>). <article-title>Generation and basic characterization of a gene-trap knockout mouse model of <italic toggle="yes">Scn2a</italic> with a substantial reduction of voltage-gated sodium channel Na <sub>v</sub> 1.2 expression</article-title>. <source>Genes, Brain and Behavior</source>, <volume>20</volume>(<issue>4</issue>), <fpage>e12725</fpage>. <pub-id pub-id-type="doi">10.1111/gbb.12725</pub-id><pub-id pub-id-type="pmid">33369088</pub-id></mixed-citation></ref><ref id="R17"><mixed-citation publication-type="journal"><name name-style="western"><surname>Echevarria-Cooper</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2023</year>). <article-title>Strain-dependent effects on neurobehavioral and seizure phenotypes in Scn2aK1422E mice</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2023.06.06.543929</pub-id></mixed-citation></ref><ref id="R18"><mixed-citation publication-type="journal"><name name-style="western"><surname>Echevarria-Cooper</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, <name name-style="western"><surname>Misra</surname><given-names>S. N.</given-names></name>, <name name-style="western"><surname>Huffman</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Thaxton</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Lipkin</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>George</surname><given-names>A. L.</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2022</year>). <article-title>Cellular and behavioral effects of altered NaV1.2 sodium channel ion permeability in <italic toggle="yes">Scn2a K1422E</italic> mice</article-title>. <source>Human Molecular Genetics</source>, <volume>31</volume>(<issue>17</issue>), <fpage>2964</fpage>&#8211;<lpage>2988</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddac087</pub-id><pub-id pub-id-type="pmid">35417922</pub-id><pub-id pub-id-type="pmcid">PMC9433730</pub-id></mixed-citation></ref><ref id="R19"><mixed-citation publication-type="journal"><name name-style="western"><surname>Echevarria-Cooper</surname><given-names>D. M.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2023</year>). <article-title>Evaluating the interplay between estrous cyclicity and flurothyl-induced seizure susceptibility in Scn2a K1422E mice</article-title>. <source>microPublication Biology, 2023</source>. <pub-id pub-id-type="doi">10.17912/micropub.biology.000850</pub-id><pub-id pub-id-type="pmcid">PMC10757737</pub-id><pub-id pub-id-type="pmid">38162411</pub-id></mixed-citation></ref><ref id="R20"><mixed-citation publication-type="journal"><name name-style="western"><surname>Fazeli</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Schattling</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Engeland</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Friese</surname><given-names>M.</given-names></name>, &amp; <name name-style="western"><surname>Isbrand</surname><given-names>D.</given-names></name> (<year>2016</year>). <article-title>The Voltage-Gated Sodium Channel Nav1.2 Contributes to Neurodegeneration in an Animal Model of Multiple Sclerosis</article-title>. <source>Neuropediatrics</source>, <volume>47</volume>(<issue>S 01</issue>), <fpage>s-0036</fpage>-<lpage>1583723</lpage>. <pub-id pub-id-type="doi">10.1055/s-0036-1583723</pub-id><pub-id pub-id-type="pmcid">PMC5111507</pub-id><pub-id pub-id-type="pmid">27882351</pub-id></mixed-citation></ref><ref id="R21"><mixed-citation publication-type="journal"><name name-style="western"><surname>Fromer</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Pocklington</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Kavanagh</surname><given-names>D. H.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Dwyer</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Gormley</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Georgieva</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Rees</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Palta</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Ruderfer</surname><given-names>D. M.</given-names></name>, <name name-style="western"><surname>Carrera</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Humphreys</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Johnson</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Roussos</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>D. D.</given-names></name>, <name name-style="western"><surname>Banks</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Milanova</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Grant</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Hannon</surname><given-names>E.</given-names></name>, &#8230; <name name-style="western"><surname>O&#8217;Donovan</surname><given-names>M. C.</given-names></name> (<year>2014</year>). <article-title>De novo mutations in schizophrenia implicate synaptic networks</article-title>. <source>Nature</source>, <volume>506</volume>(<issue>7487</issue>), <fpage>179</fpage>&#8211;<lpage>184</lpage>. <pub-id pub-id-type="doi">10.1038/nature12929</pub-id><pub-id pub-id-type="pmid">24463507</pub-id><pub-id pub-id-type="pmcid">PMC4237002</pub-id></mixed-citation></ref><ref id="R22"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gazina</surname><given-names>E. V.</given-names></name>, <name name-style="western"><surname>Leaw</surname><given-names>B. T. W.</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Wimmer</surname><given-names>V. C.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>T. H.</given-names></name>, <name name-style="western"><surname>Aumann</surname><given-names>T. D.</given-names></name>, <name name-style="western"><surname>Featherby</surname><given-names>T. J.</given-names></name>, <name name-style="western"><surname>Churilov</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Hammond</surname><given-names>V. E.</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>C. A.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2015</year>). &#8216;<article-title>Neonatal&#8217; Nav1.2 reduces neuronal excitability and affects seizure susceptibility and behaviour</article-title>. <source>Human Molecular Genetics</source>, <volume>24</volume>(<issue>5</issue>), <fpage>1457</fpage>&#8211;<lpage>1468</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddu562</pub-id><pub-id pub-id-type="pmid">25378553</pub-id></mixed-citation></ref><ref id="R23"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gazina</surname><given-names>E. V.</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>K. L.</given-names></name>, <name name-style="western"><surname>Mokhtar</surname><given-names>M. B. C.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>E. A.</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>C. A.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2010</year>). <article-title>Differential expression of exon 5 splice variants of sodium channel &#945; subunit mRNAs in the developing mouse brain</article-title>. <source>Neuroscience</source>, <volume>166</volume>(<issue>1</issue>), <fpage>195</fpage>&#8211;<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.12.011</pub-id><pub-id pub-id-type="pmid">20006674</pub-id></mixed-citation></ref><ref id="R24"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gong</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Rhodes</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Bekele-Arcuri</surname><given-names>Z.</given-names></name>, &amp; <name name-style="western"><surname>Trimmer</surname><given-names>J. S.</given-names></name> (<year>1999</year>). <article-title>Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain</article-title>. <source>The Journal of Comparative Neurology</source>, <volume>412</volume>(<issue>2</issue>), <fpage>342</fpage>&#8211;<lpage>352</lpage>.<pub-id pub-id-type="pmid">10441760</pub-id></mixed-citation></ref><ref id="R25"><mixed-citation publication-type="journal"><name name-style="western"><surname>Gould</surname><given-names>E.</given-names></name>, &amp; <name name-style="western"><surname>Kim</surname><given-names>J. H.</given-names></name> (<year>2021</year>). <article-title>SCN2A contributes to oligodendroglia excitability and development in the mammalian brain</article-title>. <source>Cell Reports</source>, <volume>36</volume>(<issue>10</issue>), <fpage>109653</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109653</pub-id><pub-id pub-id-type="pmid">34496232</pub-id><pub-id pub-id-type="pmcid">PMC8486143</pub-id></mixed-citation></ref><ref id="R26"><mixed-citation publication-type="journal"><name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, &amp; <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name> (<year>2016</year>). <article-title>Hlf is a genetic modifier of epilepsy caused by voltage-gated sodium channel mutations</article-title>. <source>Epilepsy Research</source>, <volume>119</volume>, <fpage>20</fpage>&#8211;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2015.11.016</pub-id><pub-id pub-id-type="pmid">26656780</pub-id><pub-id pub-id-type="pmcid">PMC4698075</pub-id></mixed-citation></ref><ref id="R27"><mixed-citation publication-type="journal"><name name-style="western"><surname>Hu</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hou</surname><given-names>H.</given-names></name>, &amp; <name name-style="western"><surname>Shu</surname><given-names>Y.</given-names></name> (<year>2009</year>). <article-title>Distinct contributions of Nav1.6 and Nav1.2 in action potential initiation and backpropagation</article-title>. <source>Nature Neuroscience</source>, <volume>12</volume>(<issue>8</issue>), <fpage>996</fpage>&#8211;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1038/nn.2359</pub-id><pub-id pub-id-type="pmid">19633666</pub-id></mixed-citation></ref><ref id="R28"><mixed-citation publication-type="journal"><name name-style="western"><surname>Indumathy</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pruitt</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Crane</surname><given-names>K.</given-names></name>, &amp; <name name-style="western"><surname>Glasscock</surname><given-names>E.</given-names></name> (<year>2021</year>). <article-title>Kv1.1 deficiency alters repetitive and social behaviors in mice and rescues autistic-like behaviors due to <italic toggle="yes">Scn2a</italic> haploinsufficiency</article-title>. <source>Brain and Behavior</source>, <volume>11</volume>(<issue>4</issue>), <fpage>e02041</fpage>. <pub-id pub-id-type="doi">10.1002/brb3.2041</pub-id><pub-id pub-id-type="pmid">33484493</pub-id><pub-id pub-id-type="pmcid">PMC8035482</pub-id></mixed-citation></ref><ref id="R29"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kamiya</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kaneda</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Sugawara</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Mazaki</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Okamura</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Makita</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Tanaka</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Fukushima</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Fujiwara</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>Y.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2004</year>). <article-title>A nonsense mutation of the sodium channel gene SCN2A in a patient with intractable epilepsy and mental decline</article-title>. <source>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience</source>, <volume>24</volume>(<issue>11</issue>), <fpage>2690</fpage>&#8211;<lpage>2698</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3089-03.2004</pub-id><pub-id pub-id-type="pmid">15028761</pub-id><pub-id pub-id-type="pmcid">PMC6729532</pub-id></mixed-citation></ref><ref id="R30"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kastner</surname><given-names>D. B.</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Holobetz</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Romano</surname><given-names>J. P.</given-names></name>, &amp; <name name-style="western"><surname>Dayan</surname><given-names>P.</given-names></name> (<year>2024</year>). <article-title>The choice-wide behavioral association study: Data-driven identification of interpretable behavioral components</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2024.02.26.582115</pub-id></mixed-citation></ref><ref id="R31"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Plummer</surname><given-names>N. W.</given-names></name>, <name name-style="western"><surname>Smith</surname><given-names>M. R.</given-names></name>, <name name-style="western"><surname>Kapur</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cummins</surname><given-names>T. R.</given-names></name>, <name name-style="western"><surname>Waxman</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Goldin</surname><given-names>A. L.</given-names></name>, &amp; <name name-style="western"><surname>Meisler</surname><given-names>M. H.</given-names></name> (<year>2001</year>). <article-title>A gain-of-function mutation in the sodium channel gene Scn2a results in seizures and behavioral abnormalities</article-title>. <source>Neuroscience</source>, <volume>102</volume>(<issue>2</issue>), <fpage>307</fpage>&#8211;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(00)00479-6</pub-id><pub-id pub-id-type="pmid">11166117</pub-id></mixed-citation></ref><ref id="R32"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Beyer</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Bergren</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Claes</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Dejonghe</surname><given-names>P.</given-names></name>, &amp; <name name-style="western"><surname>Frankel</surname><given-names>W. N.</given-names></name> (<year>2006</year>). <article-title>Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2</article-title>. <source>Human Molecular Genetics</source>, <volume>15</volume>(<issue>6</issue>), <fpage>1043</fpage>&#8211;<lpage>1048</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl019</pub-id><pub-id pub-id-type="pmid">16464983</pub-id></mixed-citation></ref><ref id="R33"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kile</surname><given-names>K. B.</given-names></name>, <name name-style="western"><surname>Tian</surname><given-names>N.</given-names></name>, &amp; <name name-style="western"><surname>Durand</surname><given-names>D. M.</given-names></name> (<year>2008</year>). <article-title>Scn2a sodium channel mutation results in hyperexcitability in the hippocampus in vitro</article-title>. <source>Epilepsia</source>, <volume>49</volume>(<issue>3</issue>), <fpage>488</fpage>&#8211;<lpage>499</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01413.x</pub-id><pub-id pub-id-type="pmid">18031550</pub-id><pub-id pub-id-type="pmcid">PMC2720056</pub-id></mixed-citation></ref><ref id="R34"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kim</surname><given-names>H. J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S. H.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>H. D.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>S.</given-names></name>, &amp; <name name-style="western"><surname>Kang</surname><given-names>H.</given-names></name> (<year>2020</year>). <article-title>The phenotype and treatment of <italic toggle="yes">SCN2A</italic> -related developmental and epileptic encephalopathy</article-title>. <source>Epileptic Disorders</source>, <volume>22</volume>(<issue>5</issue>), <fpage>563</fpage>&#8211;<lpage>570</lpage>. <pub-id pub-id-type="doi">10.1684/epd.2020.1199</pub-id><pub-id pub-id-type="pmid">33000761</pub-id></mixed-citation></ref><ref id="R35"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>C.-S.</given-names></name>, &amp; <name name-style="western"><surname>Kaang</surname><given-names>B.-K.</given-names></name> (<year>2016</year>). <article-title>Neuronal mechanisms and circuits underlying repetitive behaviors in mouse models of autism spectrum disorder</article-title>. <source>Behavioral and Brain Functions : BBF</source>, <volume>12</volume>, <fpage>3</fpage>. <pub-id pub-id-type="doi">10.1186/s12993-016-0087-y</pub-id><pub-id pub-id-type="pmid">26790724</pub-id><pub-id pub-id-type="pmcid">PMC4719705</pub-id></mixed-citation></ref><ref id="R36"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kotler</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Khrapunsky</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Shvartsman</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dai</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Plant</surname><given-names>L. D.</given-names></name>, <name name-style="western"><surname>Goldstein</surname><given-names>S. A.</given-names></name>, &amp; <name name-style="western"><surname>Fleidervish</surname><given-names>I.</given-names></name> (<year>2023</year>). <article-title>SUMOylation of NaV1.2 channels regulates the velocity of backpropagating action potentials in cortical pyramidal neurons</article-title>. <source>eLife</source>, <volume>12</volume>, <fpage>e81463</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.81463</pub-id><pub-id pub-id-type="pmid">36794908</pub-id><pub-id pub-id-type="pmcid">PMC10014073</pub-id></mixed-citation></ref><ref id="R37"><mixed-citation publication-type="journal"><name name-style="western"><surname>Kruth</surname><given-names>K. A.</given-names></name>, <name name-style="western"><surname>Grisolano</surname><given-names>T. M.</given-names></name>, <name name-style="western"><surname>Ahern</surname><given-names>C. A.</given-names></name>, &amp; <name name-style="western"><surname>Williams</surname><given-names>A. J.</given-names></name> (<year>2020</year>). <article-title>SCN2A channelopathies in the autism spectrum of neuropsychiatric disorders: A role for pluripotent stem cells?</article-title><source>Molecular Autism</source>, <volume>11</volume>(<issue>1</issue>), <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-020-00330-9</pub-id><pub-id pub-id-type="pmid">32264956</pub-id><pub-id pub-id-type="pmcid">PMC7140374</pub-id></mixed-citation></ref><ref id="R38"><mixed-citation publication-type="journal"><name name-style="western"><surname>Lauffer</surname><given-names>M. C.</given-names></name>, <name name-style="western"><surname>van Roon-Mom</surname><given-names>W.</given-names></name>, &amp; <name name-style="western"><surname>Aartsma-Rus</surname><given-names>A.</given-names></name> (<year>2024</year>). <article-title>Possibilities and limitations of antisense oligonucleotide therapies for the treatment of monogenic disorders</article-title>. <source>Communications Medicine</source>, <volume>4</volume>(<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1038/s43856-023-00419-1</pub-id><pub-id pub-id-type="pmid">38182878</pub-id><pub-id pub-id-type="pmcid">PMC10770028</pub-id></mixed-citation></ref><ref id="R39"><mixed-citation publication-type="journal"><name name-style="western"><surname>Lauxmann</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Verbeek</surname><given-names>N. E.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zaichuk</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>M&#252;ller</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Lemke</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Van Kempen</surname><given-names>M. J. A.</given-names></name>, <name name-style="western"><surname>Lerche</surname><given-names>H.</given-names></name>, &amp; <name name-style="western"><surname>Hedrich</surname><given-names>U. B. S.</given-names></name> (<year>2018</year>). <article-title>Relationship of electrophysiological dysfunction and clinical severity in <italic toggle="yes">SCN2A</italic> -related epilepsies</article-title>. <source>Human Mutation</source>, <volume>39</volume>(<issue>12</issue>), <fpage>1942</fpage>&#8211;<lpage>1956</lpage>. <pub-id pub-id-type="doi">10.1002/humu.23619</pub-id><pub-id pub-id-type="pmid">30144217</pub-id></mixed-citation></ref><ref id="R40"><mixed-citation publication-type="journal"><name name-style="western"><surname>L&#233;na</surname><given-names>I.</given-names></name>, &amp; <name name-style="western"><surname>Mantegazza</surname><given-names>M.</given-names></name> (<year>2019</year>). <article-title>NaV1.2 haploinsufficiency in Scn2a knock-out mice causes an autistic-like phenotype attenuated with age</article-title>. <source>Scientific Reports</source>, <volume>9</volume>(<issue>1</issue>), <fpage>12886</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-019-49392-7</pub-id><pub-id pub-id-type="pmid">31501495</pub-id><pub-id pub-id-type="pmcid">PMC6733925</pub-id></mixed-citation></ref><ref id="R41"><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Cai</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>He</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Shao</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Ran</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Xia</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Sun</surname><given-names>Z. S.</given-names></name>, &amp; <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name> (<year>2016</year>). <article-title>Genes with de novo mutations are shared by four neuropsychiatric disorders discovered from NPdenovo database</article-title>. <source>Molecular Psychiatry</source>, <volume>21</volume>(<issue>2</issue>), <fpage>290</fpage>&#8211;<lpage>297</lpage>. <pub-id pub-id-type="doi">10.1038/mp.2015.40</pub-id><pub-id pub-id-type="pmid">25849321</pub-id><pub-id pub-id-type="pmcid">PMC4837654</pub-id></mixed-citation></ref><ref id="R42"><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Eltabbal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Tran</surname><given-names>H.-D.</given-names></name>, &amp; <name name-style="western"><surname>Kuhn</surname><given-names>B.</given-names></name> (<year>2023</year>). <article-title>Scn2a insufficiency alters spontaneous neuronal Ca2+ activity in somatosensory cortex during wakefulness</article-title>. <source>iScience</source>, <volume>26</volume>(<issue>11</issue>), <fpage>108138</fpage>. <pub-id pub-id-type="doi">10.1016/j.isci.2023.108138</pub-id><pub-id pub-id-type="pmid">37876801</pub-id><pub-id pub-id-type="pmcid">PMC10590963</pub-id></mixed-citation></ref><ref id="R43"><mixed-citation publication-type="journal"><name name-style="western"><surname>Li</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Jancovski</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Jafar-Nejad</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Burbano</surname><given-names>L. E.</given-names></name>, <name name-style="western"><surname>Rollo</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Richards</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Drew</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Sedo</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Heighway</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Pachernegg</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Soriano</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Blackburn</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Roberts</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Nemiroff</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Dalby</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Maljevic</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Reid</surname><given-names>C. A.</given-names></name>, <name name-style="western"><surname>Rigo</surname><given-names>F.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2021</year>, <month>December</month><day>1</day>). <source>Antisense oligonucleotide therapy reduces seizures and extends life span in an SCN2A gain-of-function epilepsy model</source>. <pub-id pub-id-type="doi">10.1172/JCI152079</pub-id><pub-id pub-id-type="pmcid">PMC8631599</pub-id><pub-id pub-id-type="pmid">34850743</pub-id></mixed-citation></ref><ref id="R44"><mixed-citation publication-type="journal"><name name-style="western"><surname>Liao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Anttonen</surname><given-names>A.-K.</given-names></name>, <name name-style="western"><surname>Liukkonen</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Gaily</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Maljevic</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Schubert</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Bellan-Koch</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ahonen</surname><given-names>V. E.</given-names></name>, <name name-style="western"><surname>Lerche</surname><given-names>H.</given-names></name>, &amp; <name name-style="western"><surname>Lehesjoki</surname><given-names>A.-E.</given-names></name> (<year>2010</year>). <article-title>SCN2A mutation associated with neonatal epilepsy, late-onset episodic ataxia, myoclonus, and pain</article-title>. <source>Neurology</source>, <volume>75</volume>(<issue>16</issue>), <fpage>1454</fpage>&#8211;<lpage>1458</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181f8812e</pub-id><pub-id pub-id-type="pmid">20956790</pub-id></mixed-citation></ref><ref id="R45"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Tu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Que</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Wettschurack</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kimbrough</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Lanman</surname><given-names>N. A.</given-names></name>, <name name-style="western"><surname>Schust</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name>, &amp; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name> (<year>2022</year>). <article-title>Deficiency of autism-related Scn2a gene in mice disrupts sleep patterns and circadian rhythms</article-title>. <source>Neurobiology of Disease</source>, <volume>168</volume>, <fpage>105690</fpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2022.105690</pub-id><pub-id pub-id-type="pmid">35301122</pub-id><pub-id pub-id-type="pmcid">PMC9018617</pub-id></mixed-citation></ref><ref id="R46"><mixed-citation publication-type="journal"><name name-style="western"><surname>MacDonald</surname><given-names>B. T.</given-names></name>, <name name-style="western"><surname>Adamska</surname><given-names>M.</given-names></name>, &amp; <name name-style="western"><surname>Meisler</surname><given-names>M. H.</given-names></name> (<year>2004</year>). <article-title>Hypomorphic expression of Dkk1 in the doubleridge mouse: Dose dependence and compensatory interactions with Lrp6</article-title>. <source>Development (Cambridge, England)</source>, <volume>131</volume>(<issue>11</issue>), <fpage>2543</fpage>&#8211;<lpage>2552</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01126</pub-id><pub-id pub-id-type="pmid">15115753</pub-id></mixed-citation></ref><ref id="R47"><mixed-citation publication-type="journal"><name name-style="western"><surname>Marcantonio</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Simonti</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>L&#233;na</surname><given-names>I.</given-names></name>, &amp; <name name-style="western"><surname>Mantegazza</surname><given-names>M.</given-names></name> (<year>2023</year>). <article-title>Gender-specific behavioral features of juvenile and adult haploinsufficient Scn2a+/&#8722; female mice, model of Autism Spectrum Disorder</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2023.12.11.571165</pub-id><pub-id pub-id-type="pmid">40887751</pub-id></mixed-citation></ref><ref id="R48"><mixed-citation publication-type="journal"><name name-style="western"><surname>Miao</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Tang</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ye</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Lou</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, &amp; <name name-style="western"><surname>Feng</surname><given-names>J.</given-names></name> (<year>2020</year>). <article-title>Electrophysiological features: The next precise step for <italic toggle="yes">SCN2A</italic> developmental epileptic encephalopathy</article-title>. <source>Molecular Genetics &amp; Genomic Medicine</source>, <volume>8</volume>(<issue>7</issue>), <fpage>e1250</fpage>. <pub-id pub-id-type="doi">10.1002/mgg3.1250</pub-id><pub-id pub-id-type="pmid">32400968</pub-id><pub-id pub-id-type="pmcid">PMC7336724</pub-id></mixed-citation></ref><ref id="R49"><mixed-citation publication-type="journal"><name name-style="western"><surname>Middleton</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Kneller</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Ogiwara</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name>, &amp; <name name-style="western"><surname>McHugh</surname><given-names>T. J.</given-names></name> (<year>2018</year>). <article-title>Altered hippocampal replay is associated with memory impairment in mice heterozygous for the Scn2a gene</article-title>. <source>Nature Neuroscience</source>, <volume>21</volume>(<issue>7</issue>), <fpage>996</fpage>&#8211;<lpage>1003</lpage>. <pub-id pub-id-type="doi">10.1038/s41593-018-0163-8</pub-id><pub-id pub-id-type="pmid">29867081</pub-id><pub-id pub-id-type="pmcid">PMC7306226</pub-id></mixed-citation></ref><ref id="R50"><mixed-citation publication-type="journal"><name name-style="western"><surname>Mishra</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Karumuri</surname><given-names>B. K.</given-names></name>, <name name-style="western"><surname>Gautier</surname><given-names>N. M.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hutson</surname><given-names>T. N.</given-names></name>, <name name-style="western"><surname>Vanhoof-Villalba</surname><given-names>S. L.</given-names></name>, <name name-style="western"><surname>Vlachos</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Iasemidis</surname><given-names>L.</given-names></name>, &amp; <name name-style="western"><surname>Glasscock</surname><given-names>E.</given-names></name> (<year>2017</year>). <article-title>Scn2a deletion improves survival and brain&#8211;heart dynamics in the Kcna1-null mouse model of sudden unexpected death in epilepsy (SUDEP)</article-title>. <source>Human Molecular Genetics</source>, <volume>26</volume>(<issue>11</issue>), <fpage>2091</fpage>&#8211;<lpage>2103</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddx104</pub-id><pub-id pub-id-type="pmid">28334922</pub-id><pub-id pub-id-type="pmcid">PMC6075631</pub-id></mixed-citation></ref><ref id="R51"><mixed-citation publication-type="journal"><name name-style="western"><surname>Misra</surname><given-names>S. N.</given-names></name>, <name name-style="western"><surname>Kahlig</surname><given-names>K. M.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2008</year>). <article-title>Impaired NaV1.2 function and reduced cell surface expression in benign familial neonatal-infantile seizures</article-title>. <source>Epilepsia</source>, <volume>49</volume>(<issue>9</issue>), <fpage>1535</fpage>&#8211;<lpage>1545</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2008.01619.x</pub-id><pub-id pub-id-type="pmid">18479388</pub-id><pub-id pub-id-type="pmcid">PMC3647030</pub-id></mixed-citation></ref><ref id="R52"><mixed-citation publication-type="journal"><name name-style="western"><surname>Miyamoto</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tatsukawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shimohata</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Yamagata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Amano</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Mazaki</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ogiwara</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Oba-Asaka</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Hensch</surname><given-names>T. K.</given-names></name>, <name name-style="western"><surname>Itohara</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Sakimura</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kobayashi</surname><given-names>K.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2019</year>). <article-title>Impaired cortico-striatal excitatory transmission triggers epilepsy</article-title>. <source>Nature Communications</source>, <volume>10</volume>(<issue>1</issue>), <fpage>1917</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-09954-9</pub-id><pub-id pub-id-type="pmcid">PMC6478892</pub-id><pub-id pub-id-type="pmid">31015467</pub-id></mixed-citation></ref><ref id="R53"><mixed-citation publication-type="journal"><name name-style="western"><surname>Muller</surname><given-names>G. K.</given-names></name> (<year>2020</year>). <article-title>The neonatal SCN2A mutant channel mimics adult channel properties</article-title>. <source>The Journal of General Physiology</source>, <volume>152</volume>(<issue>5</issue>), <fpage>e201912468</fpage>. <pub-id pub-id-type="doi">10.1085/jgp.201912468</pub-id><pub-id pub-id-type="pmid">32291436</pub-id><pub-id pub-id-type="pmcid">PMC7201879</pub-id></mixed-citation></ref><ref id="R54"><mixed-citation publication-type="journal"><name name-style="western"><surname>Murray</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Martindale</surname><given-names>J. M.</given-names></name>, &amp; <name name-style="western"><surname>Otallah</surname><given-names>S. I.</given-names></name> (<year>2023</year>). <article-title>SCN2A - Associated Episodic and Persistent Ataxia with Cerebellar Atrophy: A Case Report</article-title>. <source>Child Neurology Open</source>, <volume>10</volume>, <fpage>2329048X2311639</fpage>. <pub-id pub-id-type="doi">10.1177/2329048X231163944</pub-id><pub-id pub-id-type="pmcid">PMC10026144</pub-id><pub-id pub-id-type="pmid">36950068</pub-id></mixed-citation></ref><ref id="R55"><mixed-citation publication-type="journal"><name name-style="western"><surname>Nadella</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ghosh</surname><given-names>A.</given-names></name>, &amp; <name name-style="western"><surname>Chu</surname><given-names>X.-P.</given-names></name> (<year>2022</year>). <article-title>Hyperexcitability in adult mice with severe deficiency in NaV1.2 channels</article-title>. <source>International Journal of Physiology, Pathophysiology and Pharmacology</source>, <volume>14</volume>(<issue>1</issue>), <fpage>55</fpage>&#8211;<lpage>59</lpage>.<pub-id pub-id-type="pmid">35310859</pub-id><pub-id pub-id-type="pmcid">PMC8918607</pub-id></mixed-citation></ref><ref id="R56"><mixed-citation publication-type="journal"><name name-style="western"><surname>Nelson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Catalfio</surname><given-names>A. M.</given-names></name>, <name name-style="western"><surname>Gupta</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Caballero-Flor&#225;n</surname><given-names>R. N.</given-names></name>, <name name-style="western"><surname>Dean</surname><given-names>K. P.</given-names></name>, <name name-style="western"><surname>Elvira</surname><given-names>C. C.</given-names></name>, <name name-style="western"><surname>Derderian</surname><given-names>K. D.</given-names></name>, <name name-style="western"><surname>Kyoung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Sahagun</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name>, &amp; <name name-style="western"><surname>Jenkins</surname><given-names>P. M.</given-names></name> (<year>2024</year>). <article-title>Physical and functional convergence of the autism risk genes <italic toggle="yes">Scn2a</italic> and <italic toggle="yes">Ank2</italic> in neocortical pyramidal cell dendrites</article-title>. <source>Neuron</source>, <volume>112</volume>(<issue>7</issue>), <fpage>1133</fpage>&#8211;<lpage>1149.e6</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2024.01.003</pub-id><pub-id pub-id-type="pmid">38290518</pub-id><pub-id pub-id-type="pmcid">PMC11097922</pub-id></mixed-citation></ref><ref id="R57"><mixed-citation publication-type="journal"><name name-style="western"><surname>Nunes</surname><given-names>D.</given-names></name>, &amp; <name name-style="western"><surname>Kuner</surname><given-names>T.</given-names></name> (<year>2018</year>). <article-title>Axonal sodium channel NaV1.2 drives granule cell dendritic GABA release and rapid odor discrimination</article-title>. <source>PLOS Biology</source>, <volume>16</volume>(<issue>8</issue>), <fpage>e2003816</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.2003816</pub-id><pub-id pub-id-type="pmid">30125271</pub-id><pub-id pub-id-type="pmcid">PMC6117082</pub-id></mixed-citation></ref><ref id="R58"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ogiwara</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Ito</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Sawaishi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Osaka</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Mazaki</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Hashikawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Shike</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Fujiwara</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kaneda</surname><given-names>M.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2009</year>). <article-title>De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies</article-title>. <source>Neurology</source>, <volume>73</volume>(<issue>13</issue>), <fpage>1046</fpage>&#8211;<lpage>1053</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b9cebc</pub-id><pub-id pub-id-type="pmid">19786696</pub-id><pub-id pub-id-type="pmcid">PMC2754324</pub-id></mixed-citation></ref><ref id="R59"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ogiwara</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Tatsukawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Yamagata</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Atapour</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Miura</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Mazaki</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ernst</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Cao</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Ohtani</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Itohara</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Yanagawa</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Yuzaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Inoue</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Hensch</surname><given-names>T. K.</given-names></name>, <name name-style="western"><surname>Noebels</surname><given-names>J. L.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2018</year>). <article-title>Nav1.2 haplodeficiency in excitatory neurons causes absence-like seizures in mice</article-title>. <source>Communications Biology</source>, <volume>1</volume>(<issue>1</issue>), <fpage>1</fpage>&#8211;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1038/s42003-018-0099-2</pub-id><pub-id pub-id-type="pmid">30175250</pub-id><pub-id pub-id-type="pmcid">PMC6115194</pub-id></mixed-citation></ref><ref id="R60"><mixed-citation publication-type="journal"><name name-style="western"><surname>Oliva</surname><given-names>M. K.</given-names></name>, <name name-style="western"><surname>McGarr</surname><given-names>T. C.</given-names></name>, <name name-style="western"><surname>Beyer</surname><given-names>B. J.</given-names></name>, <name name-style="western"><surname>Gazina</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kaplan</surname><given-names>D. I.</given-names></name>, <name name-style="western"><surname>Cordeiro</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Dib-Hajj</surname><given-names>S. D.</given-names></name>, <name name-style="western"><surname>Waxman</surname><given-names>S. G.</given-names></name>, <name name-style="western"><surname>Frankel</surname><given-names>W. N.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2014</year>). <article-title>Physiological and genetic analysis of multiple sodium channel variants in a model of genetic absence epilepsy</article-title>. <source>Neurobiology of Disease</source>, <volume>67</volume>, <fpage>180</fpage>&#8211;<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.03.007</pub-id><pub-id pub-id-type="pmid">24657915</pub-id><pub-id pub-id-type="pmcid">PMC4298829</pub-id></mixed-citation></ref><ref id="R61"><mixed-citation publication-type="journal"><name name-style="western"><surname>Oyrer</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Maljevic</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Scheffer</surname><given-names>I. E.</given-names></name>, <name name-style="western"><surname>Berkovic</surname><given-names>S. F.</given-names></name>, <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name>, &amp; <name name-style="western"><surname>Reid</surname><given-names>C. A.</given-names></name> (<year>2018</year>). <article-title>Ion Channels in Genetic Epilepsy: From Genes and Mechanisms to Disease-Targeted Therapies</article-title>. <source>Pharmacological Reviews</source>, <volume>70</volume>(<issue>1</issue>), <fpage>142</fpage>&#8211;<lpage>173</lpage>. <pub-id pub-id-type="doi">10.1124/pr.117.014456</pub-id><pub-id pub-id-type="pmid">29263209</pub-id><pub-id pub-id-type="pmcid">PMC5738717</pub-id></mixed-citation></ref><ref id="R62"><mixed-citation publication-type="journal"><name name-style="western"><surname>Passi</surname><given-names>G. R.</given-names></name>, &amp; <name name-style="western"><surname>Mohammad</surname><given-names>S. S.</given-names></name> (<year>2021</year>). <article-title>Dominant SCN2A mutation with variable phenotype in two generations</article-title>. <source>Brain &amp; Development</source>, <volume>43</volume>(<issue>1</issue>), <fpage>166</fpage>&#8211;<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2020.08.009</pub-id><pub-id pub-id-type="pmid">32893078</pub-id></mixed-citation></ref><ref id="R63"><mixed-citation publication-type="journal"><name name-style="western"><surname>Planells-Cases</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Caprini</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Rockenstein</surname><given-names>E. M.</given-names></name>, <name name-style="western"><surname>Rivera</surname><given-names>R. R.</given-names></name>, <name name-style="western"><surname>Murre</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Masliah</surname><given-names>E.</given-names></name>, &amp; <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name> (<year>2000</year>). <article-title>Neuronal Death and Perinatal Lethality in Voltage-Gated Sodium Channel &#945;II-Deficient Mice</article-title>. <source>Biophysical Journal</source>, <volume>78</volume>(<issue>6</issue>), <fpage>2878</fpage>&#8211;<lpage>2891</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3495(00)76829-9</pub-id><pub-id pub-id-type="pmid">10827969</pub-id><pub-id pub-id-type="pmcid">PMC1300874</pub-id></mixed-citation></ref><ref id="R64"><mixed-citation publication-type="journal"><name name-style="western"><surname>Ram&#237;rez-Amaya</surname><given-names>V.</given-names></name>, <name name-style="western"><surname>Balderas</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Sandoval</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Escobar</surname><given-names>M. L.</given-names></name>, &amp; <name name-style="western"><surname>Berm&#250;dez-Rattoni</surname><given-names>F.</given-names></name> (<year>2001</year>). <article-title>Spatial Long-Term Memory Is Related to Mossy Fiber Synaptogenesis</article-title>. <source>The Journal of Neuroscience</source>, <volume>21</volume>(<issue>18</issue>), <fpage>7340</fpage>&#8211;<lpage>7348</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.21-18-07340.2001</pub-id><pub-id pub-id-type="pmid">11549744</pub-id><pub-id pub-id-type="pmcid">PMC6763009</pub-id></mixed-citation></ref><ref id="R65"><mixed-citation publication-type="journal"><name name-style="western"><surname>Reynolds</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>King</surname><given-names>M. D.</given-names></name>, &amp; <name name-style="western"><surname>Gorman</surname><given-names>K. M.</given-names></name> (<year>2020</year>). <article-title>The phenotypic spectrum of SCN2A-related epilepsy</article-title>. <source>European Journal of Paediatric Neurology: EJPN: Official Journal of the European Paediatric Neurology Society</source>, <volume>24</volume>, <fpage>117</fpage>&#8211;<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2019.12.016</pub-id><pub-id pub-id-type="pmid">31924505</pub-id></mixed-citation></ref><ref id="R66"><mixed-citation publication-type="journal"><name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Campbell</surname><given-names>A. J.</given-names></name>, <name name-style="western"><surname>Cottrell</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>Moller</surname><given-names>R. S.</given-names></name>, <name name-style="western"><surname>Wagner</surname><given-names>F. F.</given-names></name>, <name name-style="western"><surname>Auldridge</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Bernier</surname><given-names>R. A.</given-names></name>, <name name-style="western"><surname>Catterall</surname><given-names>W. A.</given-names></name>, <name name-style="western"><surname>Chung</surname><given-names>W. K.</given-names></name>, <name name-style="western"><surname>Empfield</surname><given-names>J. R.</given-names></name>, <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name>, <name name-style="western"><surname>Hipp</surname><given-names>J. F.</given-names></name>, <name name-style="western"><surname>Khwaja</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Kiskinis</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lal</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Malhotra</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Millichap</surname><given-names>J. J.</given-names></name>, <name name-style="western"><surname>Otis</surname><given-names>T. S.</given-names></name>, <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name>, &#8230; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2018</year>). <article-title>Progress in Understanding and Treating SCN2A-Mediated Disorders</article-title>. <source>Trends in Neurosciences</source>, <volume>41</volume>(<issue>7</issue>), <fpage>442</fpage>&#8211;<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2018.03.011</pub-id><pub-id pub-id-type="pmid">29691040</pub-id><pub-id pub-id-type="pmcid">PMC6015533</pub-id></mixed-citation></ref><ref id="R67"><mixed-citation publication-type="journal"><name name-style="western"><surname>Schamiloglu</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kwan</surname><given-names>A. C.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2023</year>). <article-title>Dynamic Foraging Behavior Performance Is Not Affected by Scn2a Haploinsufficiency</article-title>. <source>eNeuro</source>, <volume>10</volume>(<issue>12</issue>). <pub-id pub-id-type="doi">10.1523/ENEURO.0367-23.2023</pub-id><pub-id pub-id-type="pmcid">PMC10755640</pub-id><pub-id pub-id-type="pmid">38151324</pub-id></mixed-citation></ref><ref id="R68"><mixed-citation publication-type="journal"><name name-style="western"><surname>Schattling</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Fazeli</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Engeland</surname><given-names>B.</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lerche</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Isbrandt</surname><given-names>D.</given-names></name>, &amp; <name name-style="western"><surname>Friese</surname><given-names>M. A.</given-names></name> (<year>2016</year>, <month>November</month><day>17</day>). <source>Activity of NaV1.2 promotes neurodegeneration in an animal model of multiple sclerosis</source>. <pub-id pub-id-type="doi">10.1172/jci.insight.89810</pub-id><pub-id pub-id-type="pmcid">PMC5111507</pub-id><pub-id pub-id-type="pmid">27882351</pub-id></mixed-citation></ref><ref id="R69"><mixed-citation publication-type="journal"><name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Yasumoto</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Kurahashi</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nakagawa</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Fukasawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Uchiya</surname><given-names>S.</given-names></name>, &amp; <name name-style="western"><surname>Hirose</surname><given-names>S.</given-names></name> (<year>2012</year>). <article-title>Clinical spectrum of SCN2A mutations</article-title>. <source>Brain &amp; Development</source>, <volume>34</volume>(<issue>7</issue>), <fpage>541</fpage>&#8211;<lpage>545</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2011.09.016</pub-id><pub-id pub-id-type="pmid">22029951</pub-id></mixed-citation></ref><ref id="R70"><mixed-citation publication-type="journal"><name name-style="western"><surname>Shin</surname><given-names>W.</given-names></name>, <name name-style="western"><surname>Kweon</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Kang</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S. Y.</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>S. N.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>J. Y.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>H.</given-names></name>, &amp; <name name-style="western"><surname>Kim</surname><given-names>E.</given-names></name> (<year>2019</year>). <article-title>Scn2a Haploinsufficiency in Mice Suppresses Hippocampal Neuronal Excitability, Excitatory Synaptic Drive, and Long-Term Potentiation, and Spatial Learning and Memory</article-title>. <source>Frontiers in Molecular Neuroscience</source>, <volume>12</volume>. <comment><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.frontiersin.org/articles/" ext-link-type="uri">https://www.frontiersin.org/articles/</ext-link><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="10.3389/fnmol.2019.00145" ext-link-type="doi">10.3389/fnmol.2019.00145</ext-link></comment><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fnmol.2019.00145</pub-id><pub-id pub-id-type="pmcid">PMC6582764</pub-id><pub-id pub-id-type="pmid">31249508</pub-id></mixed-citation></ref><ref id="R71"><mixed-citation publication-type="book"><name name-style="western"><surname>Spratt</surname><given-names>P.</given-names></name> (<year>2020</year>). <source><italic toggle="yes">Sodium Channel Dysfunction in Autism</italic> Spectrum Disorder (Order No. 27743754)</source>. <publisher-name>Available from ProQuest Dissertations &amp; Theses Global</publisher-name>. (<fpage>2385698907</fpage>).</mixed-citation></ref><ref id="R72"><mixed-citation publication-type="journal"><name name-style="western"><surname>Spratt</surname><given-names>P. W. E.</given-names></name>, <name name-style="western"><surname>Alexander</surname><given-names>R. P. D.</given-names></name>, <name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Sahagun</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kyoung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Keeshen</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2021</year>). <article-title>Paradoxical hyperexcitability from NaV1.2 sodium channel loss in neocortical pyramidal cells</article-title>. <source>Cell Reports</source>, <volume>36</volume>(<issue>5</issue>), <fpage>109483</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109483</pub-id><pub-id pub-id-type="pmid">34348157</pub-id><pub-id pub-id-type="pmcid">PMC8719649</pub-id></mixed-citation></ref><ref id="R73"><mixed-citation publication-type="journal"><name name-style="western"><surname>Spratt</surname><given-names>P. W. E.</given-names></name>, <name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Keeshen</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Burke</surname><given-names>K. J.</given-names></name>, <name name-style="western"><surname>Clarkson</surname><given-names>R. L.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2019</year>). <article-title>The Autism-Associated Gene Scn2a Contributes to Dendritic Excitability and Synaptic Function in the Prefrontal Cortex</article-title>. <source>Neuron</source>, <volume>103</volume>(<issue>4</issue>), <fpage>673</fpage>&#8211;<lpage>685.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2019.05.037</pub-id><pub-id pub-id-type="pmid">31230762</pub-id><pub-id pub-id-type="pmcid">PMC7935470</pub-id></mixed-citation></ref><ref id="R74"><mixed-citation publication-type="journal"><name name-style="western"><surname>Srivastava</surname><given-names>S.</given-names></name>, &amp; <name name-style="western"><surname>Sahin</surname><given-names>M.</given-names></name> (<year>2017</year>). <article-title>Autism spectrum disorder and epileptic encephalopathy: Common causes, many questions</article-title>. <source>Journal of Neurodevelopmental Disorders</source>, <volume>9</volume>(<issue>1</issue>), <fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/s11689-017-9202-0</pub-id><pub-id pub-id-type="pmid">28649286</pub-id><pub-id pub-id-type="pmcid">PMC5481888</pub-id></mixed-citation></ref><ref id="R75"><mixed-citation publication-type="journal"><name name-style="western"><surname>Suddaby</surname><given-names>J. S.</given-names></name>, <name name-style="western"><surname>Silver</surname><given-names>J.</given-names></name>, &amp; <name name-style="western"><surname>So</surname><given-names>J.</given-names></name> (<year>2019</year>). <article-title>Understanding the schizophrenia phenotype in the first patient with the full SCN2A phenotypic spectrum</article-title>. <source>Psychiatric Genetics</source>, <volume>29</volume>(<issue>3</issue>), <fpage>91</fpage>. <pub-id pub-id-type="doi">10.1097/YPG.0000000000000219</pub-id><pub-id pub-id-type="pmid">30741786</pub-id></mixed-citation></ref><ref id="R76"><mixed-citation publication-type="journal"><name name-style="western"><surname>Sundaram</surname><given-names>S. K.</given-names></name>, <name name-style="western"><surname>Chugani</surname><given-names>H. T.</given-names></name>, <name name-style="western"><surname>Tiwari</surname><given-names>V. N.</given-names></name>, &amp; <name name-style="western"><surname>Huq</surname><given-names>A. H. M. M.</given-names></name> (<year>2013</year>). <article-title>SCN2A Mutation Is Associated With Infantile Spasms and Bitemporal Glucose Hypometabolism</article-title>. <source>Pediatric Neurology</source>, <volume>49</volume>(<issue>1</issue>), <fpage>46</fpage>&#8211;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.03.002</pub-id><pub-id pub-id-type="pmid">23827426</pub-id><pub-id pub-id-type="pmcid">PMC3868437</pub-id></mixed-citation></ref><ref id="R77"><mixed-citation publication-type="journal"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mizukami</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Nakajima</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Hibi</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Kato</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Matsuzaki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ikebe</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Miyakawa</surname><given-names>T.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2023</year>). <article-title>Inversed Effects of Nav1.2 Deficiency at Medial Prefrontal Cortex and Ventral Tegmental Area for Prepulse Inhibition in Acoustic Startle Response</article-title>. <source>Molecular Neurobiology</source>. <pub-id pub-id-type="doi">10.1007/s12035-023-03610-6</pub-id><pub-id pub-id-type="pmid">37650965</pub-id></mixed-citation></ref><ref id="R78"><mixed-citation publication-type="journal"><name name-style="western"><surname>Tamura</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Spratt</surname><given-names>P. W. E.</given-names></name>, <name name-style="western"><surname>Kyoung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Holden</surname><given-names>S. S.</given-names></name>, <name name-style="western"><surname>Sahagun</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Keeshen</surname><given-names>C. M.</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hamada</surname><given-names>E. C.</given-names></name>, <name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Pan</surname><given-names>J. Q.</given-names></name>, <name name-style="western"><surname>Paz</surname><given-names>J. T.</given-names></name>, <name name-style="western"><surname>Sanders</surname><given-names>S. J.</given-names></name>, <name name-style="western"><surname>Matharu</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Ahituv</surname><given-names>N.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2022</year>). <article-title>CRISPR activation rescues abnormalities in SCN2A haploinsufficiency-associated autism spectrum disorder</article-title>. <source>bioRxiv</source>. <pub-id pub-id-type="doi">10.1101/2022.03.30.486483</pub-id></mixed-citation></ref><ref id="R79"><mixed-citation publication-type="journal"><name name-style="western"><surname>Tatsukawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Raveau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Ogiwara</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Hattori</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miyamoto</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Mazaki</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Itohara</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Miyakawa</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Montal</surname><given-names>M.</given-names></name>, &amp; <name name-style="western"><surname>Yamakawa</surname><given-names>K.</given-names></name> (<year>2019</year>). <article-title>Scn2a haploinsufficient mice display a spectrum of phenotypes affecting anxiety, sociability, memory flexibility and ampakine CX516 rescues their hyperactivity</article-title>. <source>Molecular Autism</source>, <volume>10</volume>(<issue>1</issue>), <fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/s13229-019-0265-5</pub-id><pub-id pub-id-type="pmid">30962870</pub-id><pub-id pub-id-type="pmcid">PMC6437867</pub-id></mixed-citation></ref><ref id="R80"><mixed-citation publication-type="journal"><name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Ben-Shalom</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2020</year>). <article-title>Alternative splicing potentiates dysfunction of early-onset epileptic encephalopathy SCN2A variants</article-title>. <source>The Journal of General Physiology</source>, <volume>152</volume>(<issue>3</issue>), <fpage>e201912442</fpage>. <pub-id pub-id-type="doi">10.1085/jgp.201912442</pub-id><pub-id pub-id-type="pmid">31995133</pub-id><pub-id pub-id-type="pmcid">PMC7054859</pub-id></mixed-citation></ref><ref id="R81"><mixed-citation publication-type="journal"><name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Hawkins</surname><given-names>N. A.</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2017</year>). <article-title>CaMKII modulates sodium current in neurons from epileptic <italic toggle="yes">Scn2a</italic> mutant mice</article-title>. <source>Proceedings of the National Academy of Sciences</source>, <volume>114</volume>(<issue>7</issue>), <fpage>1696</fpage>&#8211;<lpage>1701</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1615774114</pub-id><pub-id pub-id-type="pmcid">PMC5321040</pub-id><pub-id pub-id-type="pmid">28137877</pub-id></mixed-citation></ref><ref id="R82"><mixed-citation publication-type="journal"><name name-style="western"><surname>Thompson</surname><given-names>C. H.</given-names></name>, <name name-style="western"><surname>Potet</surname><given-names>F.</given-names></name>, <name name-style="western"><surname>Abramova</surname><given-names>T. V.</given-names></name>, <name name-style="western"><surname>DeKeyser</surname><given-names>J.-M.</given-names></name>, <name name-style="western"><surname>Ghabra</surname><given-names>N. F.</given-names></name>, <name name-style="western"><surname>Vanoye</surname><given-names>C. G.</given-names></name>, <name name-style="western"><surname>Millichap</surname><given-names>J. J.</given-names></name>, &amp; <name name-style="western"><surname>George</surname><given-names>A. L.</given-names></name> (<year>2023</year>). <article-title>Epilepsy-associated SCN2A (NaV1.2) variants exhibit diverse and complex functional properties</article-title>. <source>The Journal of General Physiology</source>, <volume>155</volume>(<issue>10</issue>), <fpage>e202313375</fpage>. <pub-id pub-id-type="doi">10.1085/jgp.202313375</pub-id><pub-id pub-id-type="pmid">37578743</pub-id><pub-id pub-id-type="pmcid">PMC10424433</pub-id></mixed-citation></ref><ref id="R83"><mixed-citation publication-type="journal"><name name-style="western"><surname>Trump</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>McTague</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Brittain</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Papandreou</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Meyer</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Ngoh</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Palmer</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Morrogh</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Boustred</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Hurst</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Kurian</surname><given-names>M. A.</given-names></name>, &amp; <name name-style="western"><surname>Scott</surname><given-names>R. H.</given-names></name> (<year>2016</year>). <article-title>Improving diagnosis and broadening the phenotypes in early-onset seizure and severe developmental delay disorders through gene panel analysis</article-title>. <source>Journal of Medical Genetics</source>, <volume>53</volume>(<issue>5</issue>), <fpage>310</fpage>&#8211;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2015-103263</pub-id><pub-id pub-id-type="pmid">26993267</pub-id><pub-id pub-id-type="pmcid">PMC4862068</pub-id></mixed-citation></ref><ref id="R84"><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Derderian</surname><given-names>K. D.</given-names></name>, <name name-style="western"><surname>Hamada</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Nelson</surname><given-names>A. D.</given-names></name>, <name name-style="western"><surname>Kyoung</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Ahituv</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Bouvier</surname><given-names>G.</given-names></name>, &amp; <name name-style="western"><surname>Bender</surname><given-names>K. J.</given-names></name> (<year>2024</year>). <article-title>Impaired cerebellar plasticity hypersensitizes sensory reflexes in SCN2A-associated ASD</article-title>. <source>Neuron</source>, <volume>112</volume>(<issue>9</issue>), <fpage>1444</fpage>&#8211;<lpage>1455.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2024.01.029</pub-id><pub-id pub-id-type="pmid">38412857</pub-id><pub-id pub-id-type="pmcid">PMC11065582</pub-id></mixed-citation></ref><ref id="R85"><mixed-citation publication-type="journal"><name name-style="western"><surname>Wang</surname><given-names>H.-G.</given-names></name>, <name name-style="western"><surname>Bavley</surname><given-names>C. C.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>R. M.</given-names></name>, <name name-style="western"><surname>Hackett</surname><given-names>J. E.</given-names></name>, <name name-style="western"><surname>Bayleyen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>F. S.</given-names></name>, <name name-style="western"><surname>Rajadhyaksha</surname><given-names>A. M.</given-names></name>, &amp; <name name-style="western"><surname>Pitt</surname><given-names>G. S.</given-names></name> (<year>2021</year>). <article-title>Scn2a severe hypomorphic mutation decreases excitatory synaptic input and causes autism-associated behaviors</article-title>. <source>JCI Insight</source>. <pub-id pub-id-type="doi">10.1172/jci.insight.150698</pub-id><pub-id pub-id-type="pmcid">PMC8410058</pub-id><pub-id pub-id-type="pmid">34156984</pub-id></mixed-citation></ref><ref id="R86"><mixed-citation publication-type="journal"><name name-style="western"><surname>Weiss</surname><given-names>L. A.</given-names></name>, <name name-style="western"><surname>Escayg</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Kearney</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Trudeau</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>MacDonald</surname><given-names>B. T.</given-names></name>, <name name-style="western"><surname>Mori</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Reichert</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Buxbaum</surname><given-names>J. D.</given-names></name>, &amp; <name name-style="western"><surname>Meisler</surname><given-names>M. H.</given-names></name> (<year>2003</year>). <article-title>Sodium channels SCN1A, SCN2A and SCN3A in familial autism</article-title>. <source>Molecular Psychiatry</source>, <volume>8</volume>(<issue>2</issue>), <fpage>186</fpage>&#8211;<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1038/sj.mp.4001241</pub-id><pub-id pub-id-type="pmid">12610651</pub-id></mixed-citation></ref><ref id="R87"><mixed-citation publication-type="journal"><name name-style="western"><surname>Westenbroek</surname><given-names>R. E.</given-names></name>, <name name-style="western"><surname>Merrick</surname><given-names>D. K.</given-names></name>, &amp; <name name-style="western"><surname>Catterall</surname><given-names>W. A.</given-names></name> (<year>1989</year>). <article-title>Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons</article-title>. <source>Neuron</source>, <volume>3</volume>(<issue>6</issue>), <fpage>695</fpage>&#8211;<lpage>704</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(89)90238-9</pub-id><pub-id pub-id-type="pmid">2561976</pub-id></mixed-citation></ref><ref id="R88"><mixed-citation publication-type="journal"><name name-style="western"><surname>Wolff</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Johannesen</surname><given-names>K. M.</given-names></name>, <name name-style="western"><surname>Hedrich</surname><given-names>U. B. S.</given-names></name>, <name name-style="western"><surname>Masnada</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Rubboli</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Gardella</surname><given-names>E.</given-names></name>, <name name-style="western"><surname>Lesca</surname><given-names>G.</given-names></name>, <name name-style="western"><surname>Ville</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Milh</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Villard</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Afenjar</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Chantot-Bastaraud</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Mignot</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Lardennois</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Nava</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Schwarz</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>G&#233;rard</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Perrin</surname><given-names>L.</given-names></name>, <name name-style="western"><surname>Doummar</surname><given-names>D.</given-names></name>, &#8230; <name name-style="western"><surname>M&#248;ller</surname><given-names>R. S.</given-names></name> (<year>2017</year>). <article-title>Genetic and phenotypic heterogeneity suggest therapeutic implications in SCN2A-related disorders</article-title>. <source>Brain: A Journal of Neurology</source>, <volume>140</volume>(<issue>5</issue>), <fpage>1316</fpage>&#8211;<lpage>1336</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awx054</pub-id><pub-id pub-id-type="pmid">28379373</pub-id></mixed-citation></ref><ref id="R89"><mixed-citation publication-type="journal"><name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Wettschurack</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Que</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Deming</surname><given-names>B. A.</given-names></name>, <name name-style="western"><surname>Olivero-Acosta</surname><given-names>M. I.</given-names></name>, <name name-style="western"><surname>Cui</surname><given-names>N.</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>S. M.</given-names></name>, <name name-style="western"><surname>Suzuki</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>I.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Halurkar</surname><given-names>M. S.</given-names></name>, <name name-style="western"><surname>Mandal</surname><given-names>P.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Koss</surname><given-names>W. A.</given-names></name>, &#8230; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name> (<year>2024</year>). <article-title>Microglial over-pruning of synapses during development in autism-associated SCN2A-deficient mice and human cerebral organoids</article-title>. <source>Molecular Psychiatry</source>, <volume>29</volume>(<issue>8</issue>), <fpage>2424</fpage>&#8211;<lpage>2437</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-024-02518-4</pub-id><pub-id pub-id-type="pmid">38499656</pub-id></mixed-citation></ref><ref id="R90"><mixed-citation publication-type="journal"><name name-style="western"><surname>Xu</surname><given-names>R.</given-names></name>, <name name-style="western"><surname>Thomas</surname><given-names>E. A.</given-names></name>, <name name-style="western"><surname>Jenkins</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Gazina</surname><given-names>E. V.</given-names></name>, <name name-style="western"><surname>Chiu</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Heron</surname><given-names>S. E.</given-names></name>, <name name-style="western"><surname>Mulley</surname><given-names>J. C.</given-names></name>, <name name-style="western"><surname>Scheffer</surname><given-names>I. E.</given-names></name>, <name name-style="western"><surname>Berkovic</surname><given-names>S. F.</given-names></name>, &amp; <name name-style="western"><surname>Petrou</surname><given-names>S.</given-names></name> (<year>2007</year>). <article-title>A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel</article-title>. <source>Molecular and Cellular Neurosciences</source>, <volume>35</volume>(<issue>2</issue>), <fpage>292</fpage>&#8211;<lpage>301</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2007.03.003</pub-id><pub-id pub-id-type="pmid">17467289</pub-id></mixed-citation></ref><ref id="R91"><mixed-citation publication-type="journal"><name name-style="western"><surname>Yang</surname><given-names>X.-R.</given-names></name>, <name name-style="western"><surname>Ginjupalli</surname><given-names>V. K. M.</given-names></name>, <name name-style="western"><surname>Theriault</surname><given-names>O.</given-names></name>, <name name-style="western"><surname>Poulin</surname><given-names>H.</given-names></name>, <name name-style="western"><surname>Appendino</surname><given-names>J. P.</given-names></name>, <name name-style="western"><surname>Au</surname><given-names>P. Y. B.</given-names></name>, &amp; <name name-style="western"><surname>Chahine</surname><given-names>M.</given-names></name> (<year>2022</year>). <article-title>SCN2A-related epilepsy of infancy with migrating focal seizures: Report of a variant with apparent gain- and loss-of-function effects</article-title>. <source>Journal of Neurophysiology</source>, <volume>127</volume>(<issue>5</issue>), <fpage>1388</fpage>&#8211;<lpage>1397</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00309.2021</pub-id><pub-id pub-id-type="pmid">35417276</pub-id><pub-id pub-id-type="pmcid">PMC9109789</pub-id></mixed-citation></ref><ref id="R92"><mixed-citation publication-type="journal"><name name-style="western"><surname>Zeng</surname><given-names>Q.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Duan</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Niu</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>D.</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Yang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Liao</surname><given-names>J.</given-names></name>, &amp; <name name-style="western"><surname>Zhang</surname><given-names>Y.</given-names></name> (<year>2022</year>). <article-title>SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis</article-title>. <source>Frontiers in Molecular Neuroscience</source>, <volume>15</volume>. <pub-id pub-id-type="doi">10.3389/fnmol.2022.809951</pub-id><pub-id pub-id-type="pmcid">PMC9005871</pub-id><pub-id pub-id-type="pmid">35431799</pub-id></mixed-citation></ref><ref id="R93"><mixed-citation publication-type="journal"><name name-style="western"><surname>Zhang</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>X.</given-names></name>, <name name-style="western"><surname>Eaton</surname><given-names>M.</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>J.</given-names></name>, <name name-style="western"><surname>Ma</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lai</surname><given-names>S.</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>A.</given-names></name>, <name name-style="western"><surname>Ahmad</surname><given-names>T. S.</given-names></name>, <name name-style="western"><surname>Que</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>J. H.</given-names></name>, <name name-style="western"><surname>Xiao</surname><given-names>T.</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y.</given-names></name>, <name name-style="western"><surname>Olivero-Acosta</surname><given-names>M. I.</given-names></name>, <name name-style="western"><surname>Schaber</surname><given-names>J. A.</given-names></name>, <name name-style="western"><surname>Jayant</surname><given-names>K.</given-names></name>, <name name-style="western"><surname>Yuan</surname><given-names>C.</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>Z.</given-names></name>, <name name-style="western"><surname>Lanman</surname><given-names>N. A.</given-names></name>, &#8230; <name name-style="western"><surname>Yang</surname><given-names>Y.</given-names></name> (<year>2021</year>). <article-title>Severe deficiency of the voltage-gated sodium channel NaV1.2 elevates neuronal excitability in adult mice</article-title>. <source>Cell Reports</source>, <volume>36</volume>(<issue>5</issue>), <fpage>109495</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2021.109495</pub-id><pub-id pub-id-type="pmid">34348148</pub-id><pub-id pub-id-type="pmcid">PMC8382316</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1" orientation="portrait"><label>Figure 1:</label><caption><p id="P61">Summerized main behavioral findings from the <italic toggle="yes">SCN2A</italic>
<sup>+/&#8722;</sup> mouse model. See a more detailed summary of behavioral experiments in <xref rid="SD1" ref-type="supplementary-material">Supplemental table 2</xref>. Created in BioRender. Williams lab, A. (2024) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biorender.com/b81m903" ext-link-type="uri">https://BioRender.com/b81m903</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2411.10421v1-f0001.jpg"/></fig><fig position="float" id="F2" orientation="portrait"><label>Figure 2:</label><caption><p id="P62">Summary of main behavioral findings from other constitutive haploinsufficient <italic toggle="yes">Scn2a</italic> mouse models. Model constructs not included in this summary table either did not evaluate behavior or did not identify results in their <italic toggle="yes">Scn2a</italic> model construct distinct from wildtype animals. See a more detailed summary of behavioral assessment in these animals in <xref rid="SD1" ref-type="supplementary-material">Supplementary table 2</xref>. (PTZ= pentylenetetrazole) Created in BioRender. Williams lab, A. (2024) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biorender.com/t38r001" ext-link-type="uri">https://BioRender.com/t38r001</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2411.10421v1-f0002.jpg"/></fig><fig position="float" id="F3" orientation="portrait"><label>Figure 3:</label><caption><p id="P63">Summary of main behavioral findings from <italic toggle="yes">Scn2a</italic> hypomorphic models. For a more detailed summary please See <xref rid="SD1" ref-type="supplementary-material">Supplementary table 2</xref>. Created in BioRender. Williams lab, A. (2024) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biorender.com/x74k536" ext-link-type="uri">https://BioRender.com/x74k536</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2411.10421v1-f0003.jpg"/></fig><fig position="float" id="F4" orientation="portrait"><label>Figure 4:</label><caption><p id="P64">Summary of main behavioral findings from conditional and tissue specific deletion of <italic toggle="yes">Scn2a</italic> in mice models. Model constructs not Included in this summary table either did not evaluate behavior or did not identify results in their <italic toggle="yes">SCN2A</italic> model construct distinct from wildtype animals. See a more detailed summary of behavioral assesment in these animals in <xref rid="SD1" ref-type="supplementary-material">Supplementray table 2</xref>. (VOR= Vestibular ocular reflex, SWD = Spike wake discharge) Created in BioRender. Williams lab, A. (2024) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://biorender.com/c64k310" ext-link-type="uri">https://BioRender.com/c64k310</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2411.10421v1-f0004.jpg"/></fig><fig position="float" id="F5" orientation="portrait"><label>Figure 5:</label><caption><p id="P65">Summary of findings utilizing the <italic toggle="yes">Scn2a</italic><sup>Q54</sup> mouse construct on the mixed C57BL/6J x SJI/J background Created in BioRender. Williams lab, A. (2024) <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://blorender.com/h22y889" ext-link-type="uri">https://BloRender.com/h22y889</ext-link></p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="nihpp-2411.10421v1-f0005.jpg"/></fig></floats-group></article>